The Tsim Tsoum Approaches  for Prevention of Cardiovascular
Disease by Singh, R. B. et al.
SAGE-Hindawi Access to Research
Cardiology Research and Practice
Volume 2010, Article ID 824938, 18 pages
doi:10.4061/2010/824938
Review Article
T heT s imT s o umA ppr oa c hesf o rP r ev e ntio no f
Cardiovascular Disease
R. B. Singh, FabienDeMeester, andAgnieska Wilczynska
Tsim Tsoum Institute, Ul. Golebia 2, 31-007 Krakow, Poland
Correspondence should be addressed to R. B. Singh, rbs@tsimtsoum.net
Received 27 March 2010; Accepted 15 May 2010
Academic Editor: Hector Ventura
Copyright © 2010 R. B. Singh et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The Tsim Tsoum Concept means that humans evolved on a diet in which nature recommends to ingest fatty acids in a
balanced ratio (polyunsaturated(P):saturated(S)=w-6:w-3=1:1)as part of dietary lipid pattern where monounsaturated fatty
acids(MUFA) is the major fatty acid(P:M:S=1:6:1) in the background of other dietary factors; antioxidants, vitamins, minerals
and ﬁber as well as physical activity and low mental stress. Several hundred years ago, our diet included natural foods; fruits,
vegetables, green vegetables, seeds, eggs and honey. Fish, and wild meat were also available to pre-agricultural humans which
shaped modern human genetic nutritional requirement. Cereal grains (reﬁned), and vegetable oils that are rich in w-6 fatty acids
are relatively recent addition to the human diet that represent dramatic departure from those foods to which we are adapted.
Excessoflinoleicacid,transfattyacids(TFA),saturatedandtotalfataswellasreﬁnedstarchesandsugarareproinﬂammatory.Low
dietaryMUFAandn-3fattyacidsandotherlongchainpolyunsaruratedfattyacids(LCPUFA)areimportantinthepathogenesisof
metabolic syndrome. Increased sympathetic activity with greater secretion of neurotransmitters in conjunction of underlying long
chain PUFA deﬁciency, and excess of proinﬂammatory nutrients, may damage the neurons via proinﬂammatory cytokines, in the
ventromedial hypothalamus and insulin receptors in the brain.Since, 30–50% of the fatty acids in the brain are LCPUFA, especially
omega-3 fatty acids, which are incorporated in the cell membrane phospholipids, it is possible that their supplementation may
be protective.Blood lipid composition does reﬂect one’s health status: (a) circulating serum lipoproteins and their ratio provide
information on their atherogenicity to blood vessels and (b) circulating plasma fatty acids, such as w-6/w-3 fatty acid ratio, give
indication on proinﬂammatory status of blood vessels, cardiomyocytes, liver cells and neurones; (a) and (b) are phenotype-related
and depend on genetic, environmental and developmental factors. As such, they appear as universal markers for holistic health
and these may be important in the pathogenesis of cardiovascular diseases and cancer, which is the main consideration of Tsim
Tsoum concept.
1.Introduction
The epidemic of cardiovascular disease (CVD), diabetes, and
cancer,inthewesternworldandinmiddleincomecountries,
indicates major increases in the incidence of generalized
atherosclerosis and the total burden of CVD due to changes
in the environmental factors [1–6]. Maladaptation, genetic
predisposition, environmental, dietary, and lifestyle factors
are the predominant contributors of CVD leading to the
development of these problems [1–5]. It has been suggested
that lifestyle factors such as physical inactivity and unhealthy
and unbalanced nutritional consumption of excess calories,
simple reﬁned carbohydrates with a high glycemic index
and load of high saturated fat (SF), high trans fatty acids
(TFA), high n-6 fatty acids, and lack of monounsaturated
fatty acids (MUFA) and n-3 fatty acids in the diet and
reduced exercise, can cause genetic damage, contributing to
the escalating rates of obesity and mortality due to CVD [3–
9].Hypertensionandstrokeaswellascoronaryarterydisease
(CAD), diabetes, and cancers have become a major cause
of morbidity and mortality in Asia [10–13]. The obesity
and CVD are contributing to major economic and public
health concerns and problems that mandate aggressive,
urgent, and dedicated identiﬁcation, prevention, treatment,
and education of public, private, and governmental agencies
in both developed and middle economies [4–7].2 Cardiology Research and Practice
Adverse eﬀects of the diet were known to Indians from
the ancient times, which is evident from the following
verse from an ancient scripture Bhagwad gita. “Foods which
are bitter, acid, salted, burnt, fried, and punent, give rise
to pain, mental stress, and diseases” (3100BC). Charaka
(600BC), a great physician of India, knew about the role
of diet and lifestyle in the pathogenesis of heart attack,
which would be clear from the following verse. “Heart attack
is born by the intake of fatty meals, overeating, excess of
sleep, lack of exercise, and anxiety”. Charaka Sutra, 600BC.
While Charak was suppose to live in Taxila University in
north of India and was a Brahman physician, Sushruta
was a surgeon from Vishwamitra family from Varanasi. In
mahabharata, he is represented as a son of that royal sage.
The garuda puranam places Divodasa as 4th in descent
from Dhanavantari, the ﬁrst propounder of the medical
sciences upon earth, whereas the sushruta samhita describes
both as same persons. Sushruta who was a surgeon, gave
a more clear description of atheroscerosis or madroga;
“Excess intake of fatty foods and lack of exercise causes
obesity and narrowing of the channels taking blood to the
heart. It is useful to use guggul, triphala and silajit in the
treatment”. These herbs are known to have high content
of antioxidant ﬂavonoids, vitamins and minerals as well as
ﬁbres.
In the 7th century BC, one Chinese physician proposed
that “increased consumption of salt may cause hardening of
the pulse”. About 2000 years ago from now (1st century),
Confucius, the Chinese philosopher taught his students, “the
higher the quality of foods, the better, and never rely upon
the delicacy of cooking”. Thus, a dietary guideline based on
experience, observation, and thinking was given as; “cereals,
the basic, fruits the subsidiary, meat the beneﬁcial, and
vegetable the supplementary”. Therefore, according to WHO
experts 1990, the concept of eating a diet high in animal
foodsandpreferenceformeatandgreasyfoodswasshapedin
China.However,possiblythemeatwasrichinw-3fattyacids,
and the total fat intake remained within desirable limits
and did not exceed as in the west. However, these diatary
patterns wereassociated with enormous physicalactivity and
sports such as hunting and also possibly meditation due
to introduction of Budhism, causing possibly no signiﬁcant
problem of CVDs during that period. Moreover, the meat
may have been from the running animals which has useful
fatty acid composition. It seems that Columbus diet and
lifestyle was known to Indians and Chinese from the ancient
period.
2. Causesof Mortality
Vascular variability disorders (VVDs) that are commonly
called cardiovascular diseases (CVD) are number one causes
of death globally and would be projected to remain the
leading cause of death. According to WHO estimates, 17.5
million people died from VVDs in 2005, representing 30%
of all global deaths. Coronary artery disease was the cause of
death, among 7.6 million and 5.7 million deaths were due
to stroke [1–4]. Majority of these deaths (80%) occurred
in low and middle income countries. The total world
population in 2007 was 6.6 billion including 1.3 billion
South East Asians, which would increase to 7.9 billion and
1.6 billion respectively by the year 2025. Adult population
aged 20–79 years, in the world was 4.1 billion, including
770 million South East Asians, in the year 2007, which
would increase to 5.2 billion and 1083 million respectively
by the year 2025. In one recent study [5], all causes of
mortality were infectious diseases (41.1%, n = 915) such
as tuberculosis, pneumonia, chronic obstructive pulmonary
disease, diarrhea/dyssentary, hepatitis B, and inﬂammatory
brain infections as the commonest cause of deaths in the
urban population of north India. The second most common
causes of deaths were circulatory diseases (29.1%, n =
646) including heart attacks (10.0%), stroke (7.8%), valvular
heart disease (7.2%, n = 160), sudden cardiac death,
and inﬂammatory cardiac disease, each (2.0%, n = 44).
Malignant neoplasm (5.8%, n = 131), injury (14.0%, n =
313) including accidents, ﬁre, and falls, and poisonings were
also quite common causes of death. Miscellaneous causes
o fd e a t h sw e r en o t e di n9 . 1 % ,( n = 202) death records,
including diabetes mellitus (2.2%, 49), suicides (1.8%, n =
41), congenital anomalies (1.0, n = 37), dental caries
infections (1.9, n = 42), and burns (1.3%, n = 33).
Pregnancy and perinatal causes (0.72%, n = 15) were not
commonly recorded in our study. Circulatory diseases as the
cause of mortality were signiﬁcantly more common among
higher social classes 1–3 than in lower social classes 4 and 5
whodiedmoreoften,duetoinfections.Heartattacks,stroke,
hypertension, diabetes, and obesity were signiﬁcantly more
common among higher social classes 1–3 compared to class
3 and 4 but tobacco intake showed only minor diﬀerences in
various classes.
According to Registrar General of India [7], in the year
1994 to 1998, trends indicate that there has been a signiﬁcant
decline of proportionate deaths from infectious diseases
from 22% to 16%. However, mortality from cardiovascular
diseases (CVD) increased from 21% to 25% which is lower
than death rate of 29.1 reported by Singh et al. in 2005
[5]. In Chennai, Gajalakshmi et al. [7]p e r f o r m e dv e r b a l
autopsy among 48,357 adults aged 25–69 years. Deaths due
to vascular diseases were 38.6% (n = 18, 680), followed by
cancer (8.7%), tuberculosis (5.8%), and respiratory causes
(3.5%). In another larger sample consisting of 150,000
subjects, there were 1,354 deaths in the ﬁrst year follow up
and verbal autopsy revealed that circulatory diseases as the
cause of death were noted in 34% men and 30% women.
Mohan et al. studied the mortality rates due to diabetes in
selected urban population from south India [9] among 1399
subjects (respondents 1262). During a median follow up of
6 years, deaths were signiﬁcantly greater among diabetics
compared to nondiabetics (18.9 versus 5.3 per 1000 person
years, P = .004). Mortality due to CVD were 52.9% among
diabetics and 24.2 among nondiabetics. It is clear that the
burden of CVD and diabetes appears to be quite signiﬁcant
in India indicating urgency for prevention program [4–
11]. The higher risk of CAD mortality is not explained
by conventional risk factors common among Indian immi-
grants to industrialized countries [12, 13]. Indian Society
of Hypertension and International College of Nutrition andCardiology Research and Practice 3
other experts have proposed guidelines for prevention of
CVD and diabetes in Indians and Asians, which are being
used for public education by the health workers. Social
class is a determinant of mortality including cardiovascular
mortality [4, 5]. It thus seems logical to examine whether
diﬀerences in nutritional intake exist between the social
classes, which could explain part of the existing diﬀerences
in mortality due to CVD, diabetes, and cancers [4–13].
About one ﬁfth of the adult population in developing
countries and one fourth in industrialized countries, may
have CVD and diabetes [3–6]. The prevalence of diabetes
and prediabetes were about 6% each in the year 2007 in
South East Asia, indicating that 46.5 million subjects above
20 years had this problem which would be doubled by the
year 2025. Similar targets have been calculated for CAD. The
burden of hypertension would be 4-fold greater compared to
diabetes. In various studies, the prevalence of hypertension
(>140/90mmHg) has been reported to be 22–30% in India
among urban subjects above 20 years of age. The prevalence
of CAD varies between 8% to 14% in various cities of
India. In rural population, the prevalences of diabetes,
hypertension, and CAD is 2-3 fold lower compared to urban
subjects. Dietary intake of total fat amounts to 25%–45%
in developed countries and 15%–35% of total energy in
developing countries [7]. Most of the dietary fatty acids
are derived from meats, oils, and dairy products, resulting
in marked increase in saturated and w-6 fatty acids but
relatively modest of monounsaturated fatty acids (MUFA)
and long-chain polyunsaturated fatty acids (PUFAs) [10]
particularly w-3 fatty acids. Reﬁning of vegetable oils has
been a major cause for increased consumption of w-6 fatty
acids and hydrogenation of these oils caused greater intake
of TFA, that may be the cause of mitochondrial damage
in the related organs: endothelial cells, cardiomyocytes,
smooth muscle cells, neurons, beta cells, and liver, causing
mitochondrial damage, leading to increased prevalence of
CVD, diabetes, cancers, and neurodegenerative diseases in
most countries of the world [1–9]. The increase in CVD
morbidity and mortality may be related to changes in diet
and w-3 fatty acid consumption (Tables 1, 2, 3, 4 and
5). While Japan, Greenland, and Mediterranean countries
consuming high w-3 fatty acid have lower CVD mortality,
death rates are much higher in the northern Europe, USA,
and South Asia consuming high w-6 and low w-3 diets
(Tables 4 and 5).
3. The Evolution of Diet and
the Columbus Concept
There have been marked changes in the food supply with the
developmentofagricultureabout10,000yearsagofromnow.
However, only nonsigniﬁcant change in our genes occurred,
during the past 10 century, due to presence of w-3 fatty
acids, vitamins, and minerals in the diet. The spontaneous
mutation rate for nuclear DNA is estimated at 0.5% per
million years. Hence, over the past 10,000 years there has
beentimeforverylittlechangeinourgenes,possibly0.005%.
Our genes appear to be similar to the genes of our ancestors
Table 1: Food and nutrient intake among hunter-gatherer and
western population.
Food and
nutrient Hunter-gatherer Western
population
Energy density Low High
Protein High Low-moderate
Animal High Low-moderate
Vegetable Very low Low-moderate
Carbohydrate Low-moderate (slowly
absorbed)
Moderate-rapidly
absorbed
Fiber High Low
Fat Low High
Animal Low High
Vegatable Very low High
Total w-3 High (2.3g/day) Low (0.2g/day)
Ratio w-6:w-3 Low 2.4 High 15-20
Vitamins and
minerals High low
Modiﬁed from Simopoulos 2003 [14].
during the Paleolithic period 40,000 years ago, the time
when our genetic proﬁle was established. Man appears to
live in a nutritional environment which completely diﬀers
from that for which our genetic constitution was selected.
However, it was only during the last 100–160 years that
dietary intakes have changed signiﬁcantly, causing increased
intake of saturated fatty acids (SFA) and linoleic acid, and
decrease in w-3 fatty acids, from grain-fed cattle, tamed
at farm houses, rather than meat from running animals.
There is a marked decrease in the intake of vitamins and
antioxidants. The food and nutrient intake among hunter-
gatherers and during Paleolithic period are given in Tables
1–3. There is a marked reduction in consumption of w-3
fatty acids, vitamins, minerals, and proteins and signiﬁcant
increase in the intakes of carbohydrates, (mainly reﬁned) fat
(saturated, trans fat, and linoleic acid), and salt compared to
Paleolithic period.
The Columbus concept of diet means that humans
evolved on a diet that was low in saturated fat and the
amount of w-3 and w-6 fatty acids was quite equal [15].
Nature recommends to ingest fatty acids in a balanced
ratio (polyunsaturated:saturated = w-6:w-3 = 1:1) as
part of dietary lipid pattern in which monounsaturated
fatty acids is the major fat (P:M:S = 1:6:1).Theseratios
represent the overall distribution of fats in a natural
untamed environment (www.columbus-concept.com). The
Columbus foods include egg, milk, meat, oil, and bread,
all rich in w-3 fatty acids, similar to wild foods, consumed
about 160 years ago from now. Blood lipid composition
does reﬂect one’s health status: (a) circulating serum
lipoproteins and their ratio provide information on their
atherogenicity to blood vessels and (b) circulating plasma
fatty acids, such as w-6/w-3 fatty acid ratio, give indication
on proinﬂammatory status of blood vessels; (a) and (b) are4 Cardiology Research and Practice
Table 2: Estimated fatty acid consumption in the late Paleolithic
period.
Sources Fatty acids (g/day) en
35.65/day
Plants
Linoleic acid 4.28
Alpha-linoleic acid 11.40
Animal
Linoleic acids 4.56
Alpha-linolenic acid 1.21
Total
Linoleic acid 8.84
Alpha linolenic acid 12.60
Animal
Arachidonic acid (w-6) (AA) 1.81
Eicosapentaenoic acid (w-3) (EPA) 0.39
Docosatetraenoic acid (w-6) (DTA) 0.12
Docosapentaenoic acid (w-3) (DPA) 0.42
Docosahexaenoic acid (w-3) (DHA) 0.27
Ratios of w-6/w-3
Linoleic acid/alpha linolenic acid 0.70
AA+DTA/EPA+DPA+DHA 1.79
Total w-6/w-3 0.79
Modiﬁed from Eaton et al. in Simopoulos [14].
Table 3: Nutrient composition in the late Paleolithic and current
recommendations.
Nutrient Late Paleolithic Current
recommendation
Total dietary energy %
Protein 33 12
Carbohydrate 46 58
Fat 21 30
Alcohol −0 moderate alcohol
P/S ratio 1.41 1.00
Cholesterol, mg 520 300
Fiber, g 100–150 30–60
Sodium, mg 690 1100–3300
Calcium, mg 1500–2000 800-1600
Ascorbic acid, mg 440 60
Modiﬁed from Eaton et al. in Simopoulos [14].
phenotype-related and depend on genetic, environmental,
and developmental factors. As such, they appear as universal
markers for holistic health. Blood cholesterol is central to
this approach. Its 3D-representation shows how circulating
lipoproteins aﬀect blood vessels integrity upon their
circulating throughout the body (Figure 1). Of major
importance appear the essential dietary nutrients (essential
amino acids, fatty acids, antioxidant vitamins, and minerals)
Table 4: Ethnic diﬀerences in fatty acid levels in thrombocytes
phospholipids and percentage of all deaths from cardiovascular
disease.
Europe and
USA % Japan % Greenland
Eskimos %
Arachidonic acid
(20:4w6) 26 21 8.3
Eicosapentaenoic
acid (20:5w-3) 0.5 1.6 8.0
Ratio of w-6/w-3 50 12 1
Mortality from
cardiovascular
disease
45 12 7
Modiﬁed from Weber by Simopoulos 2003 [14].
Table 5: Fatty acid ratio in the diets.
Subjects w-6/w-3
Paleolithic 0.79 Estimated
Greece prior to 1960 1.00–2.00 Current 7.10
Japan 4.00 Early 1-2
India, rural 5–6.1 Prior to 1960, 3–4
India urban 38–50 Prior to 1960, 5–10
UK 15.00 Prior to 1960, 10.00
Northern Europe 15.00 Prior to 1960, 10.00
USA 16.74 Prior to 1950 7–8
Modiﬁed from Simopoulos 2003 [3, 14].
and the functional component of the regimen (diet, sport,
spiritualism, etc.). An example is given of an essential
dietary nutrient and of a functional component of man’s
regimen that aﬀect health in a predictive way derived from
the 3D representation of blood cholesterol. Caption The
Columbus Concept and its 3D representation of blood
lipoprotein behaviors. “Bad” LDL-C, “good” HDLC, and
“healthy” LDL-CC:HDL-CC ratios. CC = Columbus
Concept. The Tsim Tsoum Concept is an extension of
the Columbus concept which includes the simultaneous
approach of controlling of Mind-brain-body connection by
diet and lifestyle changes and by modulating mental load
and circadian rhythm (Figure 2). The word Tsim Tsoum is
derived from Hebreu and it is similar to ying yang in Chinese
(http://www.tsimtsoum.net/editorials/tsimtsoum editorial
2009-Kosice-14th-WCCN-and-5th-ICCD.pdf) sachs and
group[16–18]usedDietaryApprochestoStopHypertension
(DASH). For decreasing blood pressures, blood lipoproteins,
and coronary risk. Similar dietary [19–24] interventions
have been used by other workers for the last three decades
to modulate blood pressure, obesity, diabetes, dyslipidemia
and coronary risk in patients with high risk of CVD.These
strategies appear to be similar to Columbus diet and
lifestyle which may be protective, due to a favourable fatty
acid ratio, antioxidants, and slowly absorbed nutrients in
the diet.Cardiology Research and Practice 5
Table 6: Dietary guidelines and desirable level of risk factors for
populations.
Factors Desirable Values
Energy (k calories/day) 1900–2300
Total Carbohydrate (k calories/day) 65.0
Complex Carbohydrate (k calories/day) 55.0
Total Fat (k calories/day) 21.0
Saturated Fatty Acids (k calories/day) 7.0
Polyunsaturated Fatty Acids (k calories/day) 7.0
Polyunsaturated/Saturated Fat Ratio 1.0
n-6/n-3 Fatty Acid Ratio 1:1
Dietary Cholesterol (mg/day) 100
Whole Grains (wheat, rice, corn, and
legumes) (g/day) 400–500
Fruit, vegetables, and nuts (g/day) 400–500
Salt (g/day) <6.0
Brisk Walking (km/day) 9.0
Meditation/pranayam (minutes/day) 30.0
Body Mass Index (kg/m2)
Range 19.0–23.0
Average 21.0
Waist-Hip Girth Ratio
Male <0.88
Female <0.85
Serum Total Cholesterol (mg/dL)
(4.42mmol/L) <170
Mild Hypercholesterolemia (mg/dL)
(4.42–5.20mmol/L) 170–200
Hypercholesterolemia (mg/dL)
(>5.20mmol/L) >200
Low Density Lipoprotein Cholesterol
(mg/dL) (2.32mmol/L) <90
Borderline High (mg/dL) (2.32–2.84
mmol/L) 90–110
High (mg/dL) (2.84mmol/L) >110
Triglycerides (mg/dL) (1.7mmol/L) <150
High Density Lipoprotein Cholesterol
(mg/dL) (0.9 mmol/L) >40men, >50women
Blood Pressure (mmHg) <135/88
Drug therapy in view of high risk of diabetes
and CAD.
Amblodipine, ACE-I,
receptor blockers and
new beta-blockers? Fish
oil, aspirin, and statins
Modiﬁed from Indian Consensus Group, J Nutr Environ Med, 1996.
4.Development ofCardiovascular
DiseasesandDiabetes
Overweight and central obesity, may cause clustering of risk
factors which may be characterized with impaired glucose
tolerance, with an adverse lipid proﬁle and oxidative stress
leading to hypertension and may be seen as early as in
childhood and adolescence. These risk factors, which are
indicators of metabolic syndrome and CVD, tend to be
clustered more rapidly in children and adolescents with
unhealthy lifestyles and diets such as those with excessive
intakes of saturated fats, cholesterol, reﬁned carbohydrates
and salt and inadequate consumption of dietary ﬁbre,
Essential
components
Non essential
components
Blood
cholesterol
Functional
components
Bad
Good Healthy
Figure 1: Blood cholesterol as a Marker for Holistic Health.
The Columbus Concept (www.columbus-concept.com) deals with
lifestyle’s essential components to man’s health. The Tsim Tsoum
Concept (www.tsimtsoum.net) focuses on lifestyle’s functional
components to human health. These latter diﬀer from the former
componentsinthattheydonotcontributetothedailyenergyintake
(DEI = ± 0) on the one hand, and tend to elevate man to human-
being on the other hand. They encompass those components that
characterize the noninvasive interaction of man’s body/mind with
his environment through recognition of his evolutionary nature,
that is, heritage and development.
Cardiac events
(as per RB Singh, 2004)
Deep
sleep
Sympathetic
Vagal
12:PM
6:PM
12:AM
6:AM
28.2% 16.8%
41% 13.8%
Paradoxical
sleep
Figure 2: Circadian Rhythms of ACS, Columbus & Tsim Tsoum
Concepts. Tsim Tsoum & Coloumbs around the clock.
antioxidants, vitamins, minerals, coenzyme Q10, and w-3
fatty acids. Low power mitochondria, due to coenzyme Q
deﬁciency, may be associated with reduced aerobic capacity
and predispose the metabolic syndrome and CVD [25–30].
Lack of physical activity and increase in television viewing
areotherfactorswhichfurtherincreasetheriskbydecreasing
basal metabolic rate (BMR) [1–3]. In older children and
adolescents, habitual alcohol and tobacco use also contribute
to high blood pressure and to the development of other risk
factors in early adulthood which continue to act in later life6 Cardiology Research and Practice
course. Such clustering of risk factors which is characteristic
of metabolic syndrome and CVD, represents an opportunity
toaddressmorethanoneriskfactoratatimeandmaybedue
to clustering of health related behaviours [30]. Of the several
characteristics of metabolic syndrome, at least 3 should be
present for its diagnosis. Obesity in conjunction with type
2 diabetes, hypertension, coronary artery disease (CAD),
and dyslipidemia are important features of the metabolic
syndrome which is usually associated with hyperinsulinemia
and insulin resistance [25, 26, 31].
There is coexistence of nutritional deﬁciencies and
appreciable overnutrition in the form of central obesity
and overweight in both developed and developing coun-
tries [11–13, 15–37]. Cohort studies clearly showed that
the gratifying gains in cardiovascular health occurred in
developed countries, in association with an epidemic of
CVD in the developing world [25–27, 31]. We have been
in a position to learn, the mechanism of transition from
poverty to economic development and emergence of car-
diovascular disease (CVD) [11, 32]. It seems that metabolic
syndrome is an important pathway for development of
CVD and type 2 diabetes. We proposed that “overweight
comes ﬁrst in conjunction with hyperinsulinemia, increased
angiotensin activity, increased proinﬂammatory cytokines
and central obesity followed by glucose intolerance, type 2
diabetes, hypertension, low high density lipoprotein choles-
terol(HDL)andhypertriglyceridemia(Metabolicsyndrome)
[25–27]. This sequence is followed by CAD, gall stones and
cancersand ﬁnallydental caries, gastrointestinal diseases and
bone and joint diseases, during transition from poverty to
aﬄuence”. As people become rich, they begin to increase
their dietary fat, salt and sugar (proinﬂammatory foods)
intake in the form of ready prepared foods, syrups, dairy
products and ﬂesh foods in place of grain based diet [27].
There is a greater use of automobiles, television viewing and
decrease in sports, walking and dancing as recreation. These
changesinthedietandlifestyleinconjunctionwithincreased
tobacco and alcohol intake, appear to be basic factors in the
pathogenesis of noncommunicable diseases, including CVD
[3, 31]. The last few decades of the 20th century oﬀered
us an opportunity to initiate action to counter growing
epidemics of CVD and type 2 diabetes, on both sides of
the Atlantic [25–30, 38]. When people learned the methods
of prevention, there was a decrease in CVD in the western
world but obesity continued to increase, resulting into an
increase in the metabolic syndrome in both developed and
developing economies [25, 26, 31]. It is possible that these
adverse diet and lifestyle factors damage the mitochondria of
the cardiovascular system and ventromedial hypothalamus,
leading to CVD and diabetes.
5.FattyAcids inthe DietandDevelopment of
CVDandDiabetes
Therehasbeenanenormousincreaseinw-6fattyacid(about
30g/day) in the diet due to the production of oils from
v e g e t a b l es e e d ss u c ha sc o r n ,s u n ﬂ o w e r ,s a i ﬂ o w e r ,s o y b e a n ,
and cotton. Increased intake of meat has resulted into greater
intake of arachidonic acid (0.2–1.0mg/day), whereas the
consumption of alpha-linolenic acid (ALA) has decreased
(about 0.55g/day) and the amounts of eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA) are 48 and
72mg/day, respectively, [25–29, 31, 37]. A relative and
absolute decrease in w-3 fatty acids has led to an imbalance
and increase in the ratio of w-6/w-3 fatty acids to upto 50 in
India and other developing countries, consuming vegetable
seedoils(corn,soyabean,sunﬂower,andcotton)[27–30,38–
40]. Saturated fatty acids (SFA) and trans fatty acids (TFA)
elevate, PUFA decrease and MUFA have beneﬁcial eﬀects on
total and low density lipoprotein cholesterol (LDL) as well as
on HDL cholesterol. Omega-6 PUFA and TFA also decrease
HDL cholesterol, and increase insulin resistance, free radical
stress,andinﬂammation,whichmayenhanceatherosclerosis
[27–29]. Increased intake of total fat, TFA, SFA, and w-
6 fatty acids and reﬁned carbohydrates, may cause insulin
resistance resulting into metabolic syndrome [23, 24, 31–
37]. Decreased intake of MUFA, w-3 fatty acids, ﬁber, and
phytochemicals may enhance the metabolic syndrome [15–
37].
6.CardiovascularDiseasein
Developing Countries
Coronary risk factors in the developing world include low
concentration of HDL cholesterol, hyper triglyceridemia,
abdominal obesity, high prevalence of type 2 diabetes and
CAD, and hypertension, indicating presence of metabolic
syndrome and CVD [38–41]. Sedentary lifestyle, increase in
dietary fat, reﬁned carbohydrate, and alcohol consumption
are common behaviour patterns underlying above risk
factors. Insulin resistance is nearly universal in all these
conditions and South Asians are at the greatest risk of
developing CAD and diabetes [30, 38–40]. These behaviour
patterns result into hyper insulinemia but insulin resistance
may diﬀer and may not occur in all tissues of the body.
Adipose tissue is not resistant to insulin in the early stages
of whole-body insulin resistance, but muscle is resistant very
early in the progression of metabolic syndrome X. Therefore,
physical activity and yogasans, appear to be important in
the prevention and treatment of insulin resistance. There
is no scientiﬁc evidence to demonstrate that metabolic
syndrome among South Asians is genetic in origin. It is
possible that populations in developing countries, under
scarcity, may have adapted to survive at low fat intake and
physically demanding occupations, which made them more
susceptible to dietary energy, sedentary behavior, and to
established risk factors [42–50]. Abdominal obesity (central
deposition of fat) in South Asians, appears to be universal in
all the countries, wherever they are living, but whether the
development of this type of obesity is genetic, dietary, caused
by low physical activity, or a combination of these factors
has not been established. Central obesity appears to be more
prominent in the South Asian population than in the other
Asian and Western populations. It is possible that transgenic
mice overexpressing 11β hydroxysteroid dehydrogenase type
1( 1 1 βHSD-1) selectively in adipose tissue can develop
abdominal obesity and exhibit insulin-resistant diabetes,
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[50]. It is not known whether adipose tissue from the
abdomens of South Asians show increased 11βHSD-1 activ-
ity. If this is true, peroxisome proliferator-activated receptor-
γ ligands, which markedly reduce adipocyte 11βHSD-1
activity in vitro and in vivo preferentially reduce abdominal
fat, may be the drugs of choice in South Asians to reduce
insulin resistance and obesity [43, 50] .S o u t hA s i a n sm a y
be genetically programmed or due to maladaptation may
overxpress 11βHSD-1 in their adipose tissue, which may
account for their higher risk of metabolic syndrome. It is
possible, that treatment of central obesity with these agents,
may be protective against metabolic syndrome, in South
Asians [43, 50].
Singh et al. [43], in one cross-sectional survey, among
255 rural 311 urban elderly subjects, showed that mean
blood pressures, body mass index, insulin levels, and the
prevalence of hypertension were signiﬁcantly greater among
urban compared to rural population. Total fat intake was
signiﬁcantly greater among urban and hypertensive subjects
compared to rural normotensive and hypertensive subjects,
respectively. A recent study [46], among 54 patients of
acute myocardial infarction (AMI), showed that the intake
of large meals and large breakfast >1000cal especially rich
in TFA was signiﬁcantly associated with AMI compared
to control subjects. Those consuming large meals, showed
signiﬁcantly greater levels of tumour necrosis factor-alpha
(TNF-α) and interleukin-6 (IL-6) compared to subjects
taking small breakfast. In another study [34], among 202
patients, large meals was a trigger for development of AMI
among half of the patients. TNF-α and IL-6, incidence of
known hypertension, and type-2 diabetes were signiﬁcantly
greater among AMI patients compared to healthy subjects.
These proinﬂammatory markers are risk factors of AMI
and metabolic syndrome [42]. In one cross-sectional survey
[47], among 3257 women, aged 25–64 years, social class
1–3 were consuming signiﬁcantly greater amount of total
visible fat, including TFA, clariﬁed butter (Indian ghee), and
vegetableoils,comparedtolowersocialclasses4and5.Mean
body mass index (BMI), over weight (BMI>25Kg/M2),
and central obesity (Waist-hip ratio>85) were signiﬁcantly
greater among higher social classes than lower social classes.
Higher social classes 1-3 are known to have greater
prevalence of CAD, type 2 diabetes and hypertension,
indicating metabolic syndrome in Indians. It is possible
that lower intake of w-3 fatty acids and MUFA, as well as
increased consumption of w-6 fatty acids, SFA, and TFA may
be responsible for central obesity and metabolic syndrome
among these patients [40, 47–49]. In another study [50],
among 850men, aged 25–64years, subjects were divided
into high fat, over-fat, normal-fat, and under-fat based on
criteria of body fat analysis by bioelectrical impedance. The
prevalenceofCAD,type2diabetes,andhypertension,aswell
as low HDL cholesterol, BMI, and WHR were signiﬁcantly
associated with high body fat percentage.
7. Interactionsof Gene andEnvironment
Dietary factors, physical activity, mental stress, and envi-
ronmental toxicants can inﬂuence gene expression and have
shaped the genome over several million years of human
evolution [14, 44, 49] which has given an opportunity for
health, as well as susceptibility to diseases, through genes,
while environmental factors determine which susceptible
individuals will develop metabolic syndrome. Rapid changes
in diet and lifestyle due to socioeconomic changes provide
added stress causing exposure of underlying genetic predis-
position to chronic diseases such as type 2 diabetes, obesity,
hypertension, CAD, and atherosclerosis. Several studies are
continuing on the role of nutrients in gene expression [49].
It is not clear how n-3 fatty acids suppress or decrease the
mRNA of interleukin, which is elevated in atherosclerosis,
arthritis and other autoimmune diseases, whereas n-6 fatty
acids have no such eﬀects [49]. Metabolic syndrome appears
to be polygenic in nature and rapidly escalating rates
suggesttheimportanceofenvironmentalchange,ratherthan
changes in genetic susceptibility.
It has been proposed [42–50] that genetic and other
factors,includingoxidativestress;superoxideanion(O2)and
hydrogen peroxide (H2O2), endothelial nitric oxide (eNO),
lipid peroxides, antioxidants, endothelin, angiotensin con-
verting enzyme (ACE) activity, angiotensin-II, transforming
growth factor-β (TGF-β), insulin, homocysteine, asym-
metrical dimethyl arginine, proinﬂammatory cytokines:
interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-
reactive protein (hs-CRP), long-chain polyunsaturated fatty
acids (LCPUFAs), and activity of NAD(P)H oxidase have
a role in human essential hypertension. There is a close
interaction between endogenous molecules: (endothelial
nitric oxide) eNO, endothelin, cytokines, and nutrients: folic
acid, coenzyme Q10, L-carnitine, L-arginine, tetrahydro-
biopterin (H4B), vitamin B6, vitamin B12, vitamin C, and
LCPUFAs. Statins can mediate some of their actions through
(LCPUFAs), whereas these fatty acids (especially ω-3 fatty
acids) suppress cyclooxygenase activity and the synthesis
of proinﬂammatory cytokines, and activate parasympathetic
nervous system. This activity can reduce the risk of major
vascular events. LCPUFAs such as EPA, DHA from precur-
sors to lipoxins and resolvins may have antiinﬂammatory
actions. Low-grade systemic inﬂammation seen in hyperten-
sion seems to have its origins in the perinatal period and
availability of adequate amounts of LCPUFAs during the
critical periods of brain growth prevents the development of
hypertension [14]. This indicates that preventive strategies
aimed at decreasing the incidence of hypertension and its
associated conditions suchas atherosclerosis, type 2 diabetes,
CAD, and cardiac failure in adulthood need to be prevented
during the perinatal period for primordial prevention of
metabolic syndrome.
8.DietaryFactorsandCardiovascularDisease
Experimental studies indicate that type and amount of
dietaryfattyacidsmaycauseinsulinresistanceandmetabolic
syndrome [51]. MUFA or w-3 fatty acids appear to have
beneﬁcial eﬀects on insulin action, whereas w-6 fatty acids,
saturated fats and diets with high total-fat content, appear
to decrease insulin sensitivity in animal studies [30, 38, 39].
It is hypothesized that dietary fats aﬀect the phospholipid8 Cardiology Research and Practice
composition of cell membranes in skeletal muscle and
other tissues. Several clinical studies showed a decrease
in insulin sensitivity with high fat diets [52, 53]. A few
studies diminish the strength of their conclusions, including
large diﬀerence in diets, the nonrandomized assignment of
diets, and lack of standardized methods to measure insulin
sensitivity. A few studies using more standard measures
reported a relationship between fat content and insulin
sensitivity [54]. One reason may be the relatively short
duration of intervention in many of these studies. A recent
multicenter, 3-month investigation found that a diet high in
saturated fat (18% of energy) decreased insulin sensitivity
more than a diet high in monounsaturated fat (21% of
energy) among 162 healthy men and women [55]. Many
cross-sectional epidemiologic studies also demonstrated
positive association between intake of saturated fat and
hyperinsulinemia, after adjustment for measure of body
fat [56, 57], but at least one large, well-designed study
showed no association [58]. Prospective studies including
the Nurses’ Health Study [59] suggest the role of speciﬁc
types of fat in the development of type 2 diabetes mellitus. In
the Nurses’ Health Study, investigators reported an inverse
association between development of diabetes and intake of
vegetable fat and polyunsaturated fat, a positive association
for trans-fatty acids, but no association for total fat in
the diet. In a more recent study [60], among 15 obese,
hyper insulinemic subjects, a hypoenergetic, MUFA-rich diet
containing 35% carbohydrate, 45% fat, and 20% protein
was compared with a diet containing; 60% carbohydrate,
20% fat, and 20% protein. After 4 weeks, fasting insulin
levels, insulin to glucose ratio, Homeostatic Model, and
Assessment Index decreased to normal ranges and were sig-
niﬁcantly lower in high MUFA group as compared with the
control group. However, insulin sensitivity score increased
signiﬁcantly, waist circumference showed signiﬁcant decline,
in the high MUFA group compared to high carbohydrate
group, indicating improved insulin sensitivity and decreased
central obesity, respectively, with MUFA-rich diet. In a cross-
sectional population study [61], Folsom et al. reported
among 4000 healthy subjects that fasting insulin levels were
positively associated with the percentage of saturated fat in
plasma, and inversely associated with percentage of MUFA.
Lovejoy et al. [62] observed that certain class of fatty acids
s u c ha sw - 6 ,s a t u r a t e da n dT F Ah a v em o r ed e l e t e r i o u se ﬀects
on insulin action than others, and increase the risk of type
2 diabetes mellitus and therefore metabolic syndrome. Low
and coworkers [63] found that a high MUFA diet induced
improvement in the control of type 2 diabetes as compared
tohighcarbohydratediet.Similarresultswerenotedbyother
workers [60, 64]. In one study, MUFA-rich diet also reduced
the total cholesterol to HDL-cholesterol ratio, compared to
high carbohydrate diet [65].
A greater reduction in triglyceride levels was observed
in the high MUFA group than in the high carbohydrate
group [65, 66]. These results were observed in earlier
studies [67] showing that dietary fatty acid composition
aﬀects the fatty acid composition of VLDL-triglyceride and
alterations in composition of VLDL and in the enzymes
involved in its catabolism are two mechanisms observed
in the hypotriglyceridemic eﬀect of high MUFA diets [68].
Oleic acid has also been found to cause a reduction in
triglyceride levels, possibly through increasing the removal
of triacylglycerol [69]. Moreover, olive oil has been found
topromotegastrointestinalsecretionsandstimulatestomach
emptying, thereby increasing the rate of supply of fatty acids
to the enterocytes [70], thus accelerating the rate of digestion
and absorption and faster rate of entry of chylomicrons into
the circulation. This implies that the long-term use of olive
oil may cause up-regulation of the enterocytes’ ability to
process dietary triacylglycerol and synthesize chylomicrons
[71]. However, high carbohydrate diets are known for
their hypertriglyceridemic eﬀects and glucose intolerance
[72] which appear to be due to downregulation of muscle
lipoprotein lipase (LPL) activity [73]. These adverse eﬀects
ofsuchdietscanenhancediabetesandcardiovasculardisease
or metabolic syndrome [74–78]. The Columbus concept of
diet;includingfruits,vegetables,wholegrains,nuts,w-3fatty
acidrichegg,andmeats,andColumbusoil(oliveoil+linseed
oil) in conjunction with physical activity addresses both diet
and lifestyle, may be useful in the prevention of metabolic
syndrome as well as its components [14, 79–81].
9.Dietand Inﬂammationand
Endothelial Dysfunction
Vascular indexes should be independently considered as risk
factors of atherothrombosis, because of antiinﬂammatory
eﬀects of statins, hormone replacement therapy (HRT) and
postprandial endothelial dysfunction, in relation to inﬂam-
mation [27–29] impaired vascular biology, physiology, and
biochemistry resulting into inﬂammation and endothelial
dysfunction may be independently atherothrombotic [27,
82].
There is evidence that abnormalities of the postprandial
state are important contributing factors to the development
of atherosclerosis [45, 46, 82]. Recent studies indicate that
changes in LDL cholesterol and C-reactive protein indepen-
dently correlated with coronary atherosclerosis progression
and coronary events [83, 84]. However, on treatment, C-
reactive protein was as predictive of subsequent coronary
events as was LDL cholesterol. HRT increases HDL choles-
terol, and endothelial function, as well as inﬂammation and
coagulation which are atherogenic, hence HRD has been
discarded.
Clinical data indicate that postprandial hypertriglyceri-
daemia is a risk factor for cardiovascular disease in non-
diabetic subjects and may be a predictor of carotid intima-
media thickness in type 2 diabetic patients [85]. Meal
absorption is a complex phenomenon, and postprandial
hyperlipidaemia and hyperglycaemia are simultaneously
present in the postabsorptive phase, particularly in diabetic
patients or in subjects with impaired glucose tolerance [9,
82, 85, 86]. Both postprandial hyperglycaemia and hyper-
triglyceridaemia may cause endothelial dyfunction, which is
considered an early marker of atherosclerosis [27]. Eﬀect of
diﬀerent isocaloric meals on endothelial function in both
normal subjects and type 2 diabetic patients, may be that
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be associated with endothelial dysfunction, with maximal
impairment occurring at the time of the simultaneous pres-
ence of postprandial hyperglycaemia and hypertriglyceri-
daemia [27]. The eﬀect of liquid meals rich in carbohydrates
or saturated fats may be similar. It is possible that endothelial
dysfunction induced by a high-fat meal in type 2 diabetic
patients or associated with fasting hypertriglyceridaemia
in young men could be associated with increased plasma
concentrations of asymmetric dimethylarginine, an endoge-
nous nitric oxide synthase inhibitor, suggested as a novel
cardiovascular risk factor [87].
A mild prooxidative state accompanies meal ingestion,
which results in raised circulating biomarkers of inﬂamma-
tion, adhesion, and endothelial dysfunction, all of which
are factors in the development of cardiovascular disease
[88]. The eﬀect of hyperglicaemia, hypertriglyceridaemia,
and raised free fatty acids (FFA) levels both fasting and post-
prandial, on endothelial function may be mediated through
the generation of an oxidative stress [27, 88]. The process is
supposed to involve increased superoxide generation, which
in turn inactivates nitric oxide. Superoxide and nitric oxide
combine to produce peroxynitrite, a potent and long-lived
oxidant, that is, cytotoxic, initiates lipid peroxidation and
nitrates amino acids such as tyrosine which aﬀects many
signal transduction pathways. The production of the perox-
ynitrite anion can be indirectly inferred by the presence of
nitrotyrosine(NT).AnincreaseinplasmaNTlevelshasbeen
reported in association with postprandial hyperglycaemia or
hypertrigly-cidaemia, with a cumulative eﬀect occurring in
the presence of both conditions [27–29]. It seems therefore
that oxidative stress is a mediator of the eﬀect of raised
substrate concentration in the postprandial phase [89, 90].
It is clear that what happens during the absorption phase
m a yb eo fc o n s i d e r a b l ei m p o r t a n c e ,b e c a u s ei to c c u r ss e v e r a l
timeseverydayandhumanbeingsnowspendanincreasingly
greater part of their lives in the postprandial phase without
periods of fasting. These biological markers after a high-fat
meal, also rich in reﬁned carbohydrates, appear to be basic
underlying mechanism for insulin resistance and metabolic
syndrome leading to CVD [91].
10. Proinﬂammatory Macronutrients
Proinﬂammatory macronutrients such as w-6 fatty acids,
T F Aa n dS F Aa sw e l la sr e ﬁ n e dc a r b o h y d r a t e si n t a k em a y
produce oxidative stress and proinﬂammatory substances
[27] (Figures 1 and 2). Glucose ingestion in normal subjects
is associated with increased superoxide generation in leuko-
cytes and mononuclear cells, as well as with raised amount
and activity of nuclear factor-κB( N F - κB), a transcriptional
factor regulating the activity of at least 125 genes, most of
which are proinﬂammatory [91]. Increased consumption of
reﬁned carbohydrates also causes an increase in two other
proinﬂammatory transcription factor, activating protein-1
(AP-1), and Egr-1, the ﬁrst regulating the transcription
of matrix metalloproteinases and the second modulating
the transcription of tissue factor and plasminogen activa-
tor inhibitor-1 [27, 91]. A mixed meal from a fast-food
chain has also been shown to induce activation of NF-κB
associated with the generation of reactive oxygen species
(ROS) by mononuclear cells. Superoxide anion appear to
be an activator of at least two major proinﬂammatory
transcription factor, NF-κB and AP-1. These observations
are consistent with previous ﬁndings, demonstrating that
after oral or intravenous glucose challenges, in both normal
subjects and patients with type 2 diabetes mellitus, there is
an increased generation of ROS and raised circulating levels
of proinﬂammatory cytokines, such as TNF-α, IL-6, and IL-
18 [27, 92–94]. In apparently healthy subjects, a single high-
f a tm e a lp r o d u c e se n d o t h e l i a la c t i v a t i o n ,a se v i d e n c e db y
increased concentrations of the adhesion molecules VCAM-
1 (vascular cell adhesion molecule-1) and ICAM-1 (inter-
cellular adhesion molecule-1), in association with raised
plasma concentrations of IL-6 and TNF-α [27]. A high-fat
meal [94] may increase the circulating levels of IL-18, a
proinﬂammatorycytokinesupposedtobeinvolvedinplaque
destabilization associated with the simultaneous decrease of
circulating adiponectin, an adipocyte-derived protein with
insulin sensitizing, antiinﬂammatory, and antiatherogenic
properties [95].
11.Diet,andInsulinResistance
Biological dysfunctions, found in diabetes, obesity, and
the metabolic syndrome include, among others, increases
in the circulating levels of metabolites, such as FFA and
triglycerides, and cytokines such as TNF-α and IL-6. Admin-
istrationofamarcronutrient,causesashifttowardsoxidative
stress and inﬂammation, which in turn may reduce insulin
sensitivity. FFA as well as proinﬂammatory markers have
been shown to predict type 2 diabetes independent of
known risk factor [96, 97]. Both FFA and TNF-α have also
been shown to activate inhibitor K kinase β (IKK-β)i n
adipocytes and hepatocytes, which can then increase the
serine phosphorylation of insulin receptor substrate1 (IRS-
1), with subsequent reduction in insulin-dependent tyrosine
phosphorylation of IRS-1, and ultimately glucose transport
[98]. IKKβ is a serine kinase that controls the activation of
NK-κB, a transcription factor associated with inﬂammation.
IRS-1 may be directly phosphorylated by IKK-β at serine
residues, respresenting a novel class of substrates for IKKβ
[99]. In one recent study [100] in which hepatic expression
of the lkappaBalpha superrepressor, which reduces IKKβ
activity, reversed the phenotype of wild-type mice fed diet.
It is possible that lipid accumulation in the liver leads to
subacute hepatic “inﬂammation” through NK-κBa c t i v a t i o n
and downstream cytokine production resulting into insulin
resistance both locally in liver as well as systemically.
Circulation of IL-6 in plasma is at high concentrations
and is associated with insulin resistance in men and in
obese or hyperandrogenic women [27]. Circulating IL-6
levels and insulin sensitivity relationships seem to occur
in parallel to increases in plasma FFA. In contrast to IL-
6a n dT N F - α, adiponectin mRNA is reduced in adipose
tissue from patients with type 2 diabetes [95]. It seems
that low adiponectin production contributes to insulin
resistance and there is evidence that adiponectin decreases
circulating FFA levels by increasing fatty acid oxidation by10 Cardiology Research and Practice
skeletal muscle [101]. The endogenous proinﬂammatory
potential may be greater, in the postprandial phase, due
to imbalance in pro and antiinﬂammatory cytokines, par-
ticularly following the ingestion of rapidly absorbed foods.
Modiﬁcation of circulating FFA levels may mediate a part
of this eﬀect and blunting of antiinﬂammatory actions of
insulin might also play a role. Insulin causes a suppression
of NK-κB, at physiologically relevant concentrations, thus
reducing the production of some of its transcripts, namely
IL-6 and TNF-α [27]. This beneﬁt of insulin, has been
related to its ability to induce the release of nitric oxide
and to enhance the expression of constitutive nitric oxide
synthase.
12. DietaryApproaches to Stop
Endothelial Damage
The vascular eﬀects of high sugar and high fat meals have
greatly increased our understanding about the role of diet on
atherothrombosis[28].Thereisincreasedﬂuxofnutrientsin
the postprandial state which is associated with an increase in
circulating levels of proinﬂammatory cytokines, recruitment
of netrophils and oxidative stress. The generation of reactive
oxygen species (ROS) may be a common ground for all
these ﬁndings and may help understanding current dietetic
recommendationsoftheInternationalCollegeofCardiology,
emphasizing increased consumption of fruits, vegetables,
(400g/day), nuts (50g/day), and grains (400g/day), spices,
and MUFA+w-3 fatty acids rich oils (30–50g/day). Fruits,
vegetables, nuts and spices are rich in natural antioxidants,
phytochemicals, and ﬁbre that help ﬁghting the oxidant
wave of meals. Decreasing the intake of w-6, trans- and
saturated fatty acids and increasing the consumption of
omega-3 fatty acids (lin, mustered, and canola oil) and
MUFA (olive oil) are also considered important strategies
to reduce CAD and metabolic syndrome [25, 26, 31].There
is evidence that these two strategies are also associated
with a reduced inﬂammatory status. In the Nurses Health
Study, levels of C-reactive protein and markers of endothelial
dysfunction were 73% higher in the highest quintile of trans-
fatty acids intake, compared with the lowest quintile [102]
and low-cholesterol/low-saturated fat diets are associated
with mitigation of low-grade systemic inﬂammation which
correlated with reduction of plasma C-reactive protein levels
[103]. Cross-sectional study from the Nurses’ Health Study I
cohort demonstrated lower concentrations of many markers
of inﬂammation and endothelial activation, including C-
reactive protein, IL-6, and E-selectin, among those in the
highest quintile of omega-3 fatty acids, when compared with
thelowestquintile[104].Sinceahighintakeofomega-6fatty
acids may reduce the known beneﬁcial eﬀects of omega-3
fatty acids on CAD risk [49]; a combination of both types of
fatty acids in a ratio of 1:1 as advised by Columbus concept
Institute, which may be associated with the lowest level of
inﬂammation [105].
However, it seems that w-6/w-3 ratio in the diet should
be <5.0 to have optimal beneﬁt of these fatty acids in
the prevention of CVD, type 2 diabetes, and metabolic
syndrome.
Since free radical stress is supposed to play a key role
in the development of atherosclerosis, antioxidant-vitamin
supplementation has been suggested for the treatment and
prevention of chronic diseases, including CAD [44]. The
encouraging results of short-term trials in participants with
coronary atherosclerosis were not conﬁrmed in large-size
intervention trials. It seems that it is wrong to focus on a
single element of the diet; guideline from some professional
or governmental panels recommend to consume vitamins
and minerals from food sources, rather than from supple-
ments [44, 105]. A shift towards energy dense, reﬁned, ready
prepared foods with high glycemic index (reﬁned starches
and sugar) and unhealthy lipids (TFA, SF, and w-6 rich
oils) poor in phytochemicals and ﬁbre have been adopted by
increased number of people and populations in the western
world and in the urban populations of middle income
countries in the last few decades [26, 42–48]. These changes
in diet can cause an inctivation of innate immune system,
by excessive production of proinﬂammatory cytokines and
reduced production of antiinﬂammatory cytokines, which
may result into generation of inﬂammatory milieu, caus-
ing insulin resistance, and endothelial dysfunction. These
changes in diet in conjunction with inadequate physical
activity appear to be responsible for the development of
positive energy balance, weight gain, and central obesity,
which is widely acknowledged as an endocrine organ,
secreting an increasing number of mediators, including
proinﬂammatory cytokines [106]. Central obesity is a key
promoter of low grade systemic inﬂammatory state [85,
86] and is characterized by the most severe metabolic
abnormalities [28]. It seems that subjects with abdominal
adiposity are particularly prone to the proinﬂammatory
eﬀects of unhealthy diets. The changes in dietary patterns
thatoccurredinrecentyearsarecharacterisedwiththeintake
of large amount of foods that seem faster in preparations
and producing health damage. One prospective CARDIA
(Coronary artery risk development in young adults) study
indicate that frequent fast food intake causes weight gain and
risk of insulin resistance, over 15 years [107].
The Quebec Family Study has shown that a decrease in
the consumption of fat-foods or an increase in consumption
of whole grains and fruits predicted a lower increase in
body weight and adiposity indicators, over a 6-year follow-
up [108]. However, no speciﬁc dietary recommendations
have been advocated by health agencies for the treatment of
insulin resistance or the metabolic syndrome [44, 80, 81].
Given that the metabolic syndrome is an identiﬁable and
potentially modiﬁable risk state for both type 2 diabetes
and cardiovascular disease, adopting a dietary pattern as
that used by other workers may reduce the potential risk
of these diseases [44, 109–113]. In one study, Knoops et
al. [114], (Colleagues from the Netherlands, France, Spain
and Italy) have demonstrated that in European men and
women aged 70–90, adherence to a Mediterranean-style diet,
which represents a solid example of a healthy dietary pattern,
moderate alcohol consumption, nonsmoking status, and
physical activity was associated with a lower rate of all-cause
mortality. This combination of healthy diet and lifestyle,
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of those with none or only one of these protective factors.
Another larger study, involving about 22000 adults, showed
an inverse correlation between a greater adherence to a
Mediterranean-style diet and death [115]. Approximately a
2/9 increment in the Mediterranean diet score was associated
with a 25% reduction in total mortality and a 33% reduction
in CAD mortality.
13. InterventionTrials
Intervention trials, using the whole diet approach so far
produced are also in line with this epidemiological evidence.
In the Lyon Diet Heart Study [116], 605 patients who
had a myocardial infarction were randomly assigned to a
“Mediterranean-style” diet or a control diet resempling the
American Heart Association Step I diet. The Mediterranean
diet model supplied 30% of energy from fats and <10%
of energy from saturated fatty acids, whereas the intake of
18:3 (n-3) (α-linolenic acid) provided >0.6% of energy.
After a mean follow-up of 27 months, the risk of new acute
myocardial infarction and episodes of unstable angina was
reduced by ∼70% by the Mediterranean diet. Moreover,
total mortality was also reduced by 70%. Singh et al. [109]
tested an “Indo-Mediterranean diet” in 1000 patients in
India, with existing coronary disease or at high risk for
coronary disease. When compared with the control diet,
the intervention diet characterized by increased intake of
mustard or soyabean oil, nuts (walnuts, almonds), veg-
etables, fruits and whole grains-reduced the rate of fatal
myocardial infarction by one-third and the rate of sudden
death from cardiac causes by two-thirds. Esposito et al.
[110], randomized 180patients (99men, 81women) with
the metabolic syndrome to a Mediterranean style diet,
characterized with whole grains, vegetables, fruits, nuts, and
olive oil versus a cardiac-prudent diet with fat intake <30%.
After a follow up of 2 years, subjects in the intervention
diet showed greater weight loss, had lower C-reactive pro-
tein and proinﬂammatory cytokine levels, had less insulin
resistance, as well as lower total cholesterol and triglycerides
and higher HDL cholesterol. The prevalence of metabolic
syndrome was reduced to one half. The Japan Public Health
Centre-based study [111] showed that eating more w-3
fatty acids by increased intake of ﬁsh was associated with
signiﬁcant reduction in cardiovascular disease and cardiac
mortality.
14. The IndianExperimentsof InfarctSurvival
Acute myocardial infarction(AMI) is associated with
hyperglycemia, hypertrigly- ceridemia, hyperinsulinemia,
increased FFA, free radical stress, IL-6, TNF-alpha, and
deﬁciency of antioxidant vitamins and w-3 fatty acids,
which appear to be responsible for complications and deaths
among these patients [27, 112, 113, 117–127]. Therefore,
AMI or acute coronary syndrome (ACS) appears to be
the best model to examine the eﬀects of any intervention
on various biochemical markers and associated factors
during AMI. Recent studies [28–30], indicate that eating
high-fat, reﬁnd carbohydrate-rich fast foods (western
diet), can produce a similar proinﬂammatory state in our
body, resulting into endothelial dysfunction, which may
have adverse eﬀects in patients with AMI. It is therefore
logical to avoid western diet in patients with ACS, and
administer diet which is beneﬁcial to vascular endothelium
and myocardium. There is limited evidence regarding
the role of dietary intervention in patients with AMI
[112, 113, 117, 118]. The aim of the Indian experiment was
to determine the eﬀects of a diet rich in w-3 fatty acids,
vitamins, minerals and antioxidants (fruits, vegetables,
legumes, walnuts, almonds, ﬁsh, mustoard, and soyabean
oils) and low in reﬁned carbohydrates, in patients with
(AMI) [113, 117–119].
All patients with a diagnosis of ACS were assigned to an
intervention diet (n = 204) or a control diet (n = 202)
within 48 hours of the onset of the symptoms of AMI. The
intervention group was advised to consume 600g/day of
fruits, vegetables, legumes, and almonds, and walnuts, in a
soup or semisolid form. Tomato soup, skimmed milk, and
curd (yogurt) were commonly used to mix crushed almonds
and walnuts and other foods, which were grilled with
mustered oil. The control group was advised a low-fat diet
consistent with National Cholesterol Education Program.
Clinical characteristics, time elapsed from symptom onset
to the index infarction, site of infarction, drug therapy, and
ﬁnal diagnosis were comparable between the two groups.
Intakeoffoodsandselectednutrientswasassessedduringthe
1week and after 1year. After 1week, plasma lipid peroxides,
vitamin C, and lactate dehydrogenase levels were deter-
mined.Comparedwiththecontrolgroups,patientsallocated
to the dietary intervention consumed signiﬁcantly greater
amounts of fruit, vegetables, pulses, almonds, walnuts, oils,
and ﬁsh both during the ﬁrst trial week [113]a n d1 y e a r
after AMI [118]. The consumption of n-3 fatty acids was
also signiﬁcantly greater in the intervention group than in
the control group (1.8 ± 0.66 versus 0.65 ± 0.4gday
−1,P<
.01, Table 2 ). The consumption of proinﬂammatory foods,
such as butter and clariﬁed butter, reﬁned starches and sugar
were signiﬁcantly greater in the control group than in the
intervention group (Table 2). Plasma lipid peroxide level
decreased signiﬁcantly in the intervention group compared
with the control group, indicating a decrease in oxidative
stress which is protective against proinﬂammatory IL-6 and
TNF-alpha as well as endothelial disfunction, although these
data were not measured in our study. Lactate dehydrogenase
(LDH) level increased less in the intervention group than
in the control group, indicating that myocardial damage
was prevented by the cardioprotective diet (Table 3). The
increasedintakeofn-3fattyacidsfrommustardandsoybean
oilassociatedwiththeMediterraneandietmightberesponsi-
ble for the signiﬁcant reduction in the cardiac enzyme LDH
and lipid peroxides in the intervention compared with the
control group. Total cardiac events, including fatal and non-
fatal myocardial infarctions and sudden cardiac deaths, were
signiﬁcantly lower in the intervention group compared with
the control group, both after 6 weeks [117]a sw e l la sa f t e r
one year (Table 4)[ 118]. These Beneﬁcial eﬀects may be due
to protection of mitochondria from damageing eﬀects of free
radicals.12 Cardiology Research and Practice
The eﬀects of 1year of treatment with ﬁsh oil (122
patients, eicosapentaenoic acid, EPA 1.08g day
−1) mustard
oil (120 patients, alpha-linolenic acid 2.9g day
−1), and
no treatment (118 patients, placebo group) on the out-
come of patients with suspected AMI were compared in
a randomized, placebo-controlled trial) [120]. Treatments
were administratered within, on average 18h of onset of
symptoms. Clinical characteristics, extent of cardiac damage
and rise of cardiac enzymes and lipid peroxides were
comparable among the three groups at study entry. After
randomization, angina pectoris (18.0% and 21.6% versus
42.3%), arrhythmias (13.1% and 13.3% versus 28.7%) and
poor left ventricular function (22.8% and 26.6% versus
47.4%) were signiﬁcantly lower in the ﬁsh oil and mustard
oil treatment groups compared with the placebo group.
Sudden cardiac deaths (1.6% and 1.6% versus 6.6%), total
cardiac deaths (11.4% and 13.3% versus 22.0%) non-fatal
infarctions (13.0% and 15.0% versus 25.4%), and total
cardiac events (24.5% and 28.2% versus 47.4%) were also
signiﬁcantly lower in the two intervention groups. A modest
improvement in dyslipidaemia and a decrease in oxidative
damage were observed in the ﬁsh oil and mustard oil groups
but not in the placebo group. On the third and the ﬁfth
day after AMI, serum glutamic oxalotransaminase (SGOT)
and LDH cardiac enzymes showed greater decline in the
ﬁsh oil and mustard oil groups compared with the placebo
group. These intervention trials indicate that further studies
should be conducted with Columbus diet and Columbus oil
(olive oil+lin seed oil) in patients with AMI, to demonstrate,
cytokine and endothelial function mediated mechanisms, in
the pathophysiology of complications and deaths, among
these patients.
There is no precise and proven guideline for dietary
advice,inpatientswithAMI,whichmaybeprotectiveagainst
recurrent cardiac events. A Columbus soup (tomatoes,
grapes, vegetables, walnuts, almonds, lin seed, and olive
oil) or yogurt containing, walnuts, almonds, raisins, could
be prepared for ready use, for nonpharmacological inter-
vention, among patients of AMI. Such recepies have been
commonly used by us in our studies and clinical practice
[113, 117–123]. These strategies can inﬂuence receptors,
enzymes and nitric oxide (NO) secretion via increased intake
of w-3 fatty acids [124, 125] which are protective. These
methods are similar to dietary approaches proposed in the
theDASHdietusedinearlierstudies[16–18]inpatientswith
multipleriskfactorsofCAD,indicatingmetabolicsyndrome.
The eﬀects of diet on dyslipedimia and glucose were much
better when these dietary interventions were combined with
exercise [58, 59].
15. Recommendations
It is clear that high doses of EPA and DHA (3 to 4g/day)
have been shown to increase systemic arterial compliance,
indicating that marine omega-3 PUFAs improve endothe-
lial function [27, 126–129]. Therefore, a diet containing
ﬁsh or ﬁsh oil supplements or columbus foods (eggs,
chicken, and oils) rich in w-3 fatty acids [130], may be
advised to provide protection against western diet-induced
inﬂammation. Studies with ALA have been conﬂicting, with
some positive and some negative studies. In a controlled
trial [32], Columbus eggs showed beneﬁcial eﬀects on blood
lipoproteins. Additionally, the omega-3 PUFAs exhibit an
antiinﬂammatory eﬀect. EPA and DHA reduced tumor
necrosis factor, interleukin-6, vascular cellular adhesion
molecule-1, and E-selectin at relatively low doses ranging
from 0.3 to 1g/day. Although fewer studies have been
performed, the results have been mixed with respect to the
eﬀect of ALA on inﬂammatory markers such as C-reactive
protein, vascular cellular adhesion molecule-1, E-selectin,
and interleukin-6. The mechanistic studies with EPA and
DHA have pointed to an antiarrhythmic eﬀect, and data
with ALA are less conclusive. Studies attempting to attribute
other antiatherogenic properties to EPA, DHA, and ALA
have not been consistent, and many of these studies have
demonstrated eﬀects at doses much higher than those used
in clinical end point trials. As a result of the previously
mentioned omega-3 PUFA trials and recent epidemiologic
evidence, the American Heart Association has published
guidelinesfortheconsumptionofﬁshandﬁshoil,indicating
thatpatientswithCADshouldtrytoconsumeacombination
of EPA and DHA totaling 1 g/day. Many patients, however;
do not enjoy eating ﬁsh or have concerns about pollutants.
RichsourcesofALA,includingcanola,linandﬂaxseedmeal,
and walnuts, can be easily incorporated into the western
diets.
Columbus oil containing olive oil+lin seed oil could be
the best combination along with western diet, for prevention
of metabolic syndrome. If clinical trials demonstrate that
A L Ai sa se ﬀective as EPA and DHA in reducing cardiovascu-
larevents,thepublichealthimplicationscouldbesigniﬁcant.
The evidence supports a role for ﬁsh oil (EPA, DHA) or
ﬁsh in secondary prevention, because the clinical trials have
demonstratedareductionintotalmortality,CHDdeath,and
sudden death. The evidence from these trials has indicated
that EPA plus DHA supplementation in the range of 0.5
to 1.8g/day provides signiﬁcant beneﬁt. More research is
needed to determine whether the beneﬁts of ﬁsh oil or ﬁsh
extend to the world population in secondary and primary
prevention.
The data on the plant-based n-3 PUFA, ALA, is very
promising. However, the existing studies were small, and a
large randomized controlled trial is needed before recom-
mendations can be deﬁnitely made for CHD prevention.
The data for ALA indicate, possible reductions in sudden
death and nonfatal myocardial infarction, suggesting other
potential cardioprotective mechanisms other than a pre-
dominately antiarrhythmic role. An urgent need exists to
perform more clinical trials with ALA because the results of
such trials could have signiﬁcant public health implications.
Recommendations are given in Table 6.
Diet and lifestyle intervention can reduce the risk for
conversion of IFG/IGT to type 2 diabetes. Clinical studies,
indicate that metformin or thiazolidinediones also reduce
risk for type 2 diabetes in people with IFG or IGT. On
the other hand, no clinical trial evidence indicates that
these drugs will reduce risk for cardiovascular disease
events in patients with the metabolic syndrome. Currently,Cardiology Research and Practice 13
metformin, or thiazolidinediones are not recommended
solely for the prevention of diabetes. The cost-eﬀectiveness
of this approach has not been established. When patients
with type 2 diabetes concomitantly exhibit other features
of the metabolic syndrome they are at particularly high
risk for cardiovascular disease. Clinical trials show that high
priority should be given to treatment of dyslipidaemia and
hypertension. Glycaemic control to a haemoglobin A1c of
less than 7% will reduce microvascular complications and
coulddecreaseriskformacrovasculardiseaseaswell.Theuse
of lipid-altering, antihypertensive, and hypoglycaemic drugs
can modify insulin sensitivity and bodyweight. Metformin
and thiazolidinedi-ones improve insulin sensitivity but have
discrepant eﬀects on body weight: metformin reduces weight
whereasthiazolidinedionesincreaseit.Theincreaseinweight
in patients treated with insulin secretagogues (sulfonylureas
and repaglinide or nateglinide) and insulin results mostly
from improved glycaemic control and increases in caloric
intake as a result of hypoglycaemia. With the exception
of nicotinic acid, lipid-altering drugs do not aﬀect insulin
sensitivity or weight, whereas the eﬀect of antihypertensive
drugs is more complex. Beta-adrenergic blockers and thi-
azide diuretics might decrease insulin sensitivity but less
so at low doses, whereas ACE inhibitors and angiotensin
II receptor antagonists have variable eﬀects. By uncertain
mechanisms, ACE inhibitors and angiotensin II receptor
antagonists seem to decrease the incidence of type 2 diabetes.
Thrombogenic risk factors are characterised by ele-
vations of ﬁbrinogen, plasminogen activator inhibitor 1,
and possibly other coagulation factors. The only available
clinical approach to an increased risk for arterial thrombosis
in patients with diabetes is low-dose aspirin or other
antiplatelet drugs. These drugs are universally recommended
unless contraindicated in patients with established cardio-
vascular disease. Their eﬃcacy in patients with type 2
diabetes in the absence of cardiovascular disease has not
been established through clinical trials, although they are
widely recommended. In other people with the metabolic
syndrome, coenzyme Q10 and aspirin prophylaxis are a
therapeutic option when the risk for cardiovascular disease
events is judged to be relatively high. A proinﬂammatory
state or premetabolic syndrome is identiﬁed by elevated
cytokines (e.g., TNF-alpha and interleukin 6) as well as by
elevations in acute phase reactants (C-reactive protein and
brinogen).AnelevatedconcentrationofC-reactiveproteinis
widely thought to be an indicator of a proinfammatory state
and to be associated with higher risk for both cardiovascular
disease and diabetes. Lifestyle therapies, especially weight
reduction, moderate physical activity and alcohol intake in
moderation might reduce concentrations of this cytokine
and thus can mitigate an underlying inﬂammatory state.
No speciﬁc antiinﬂammatory drugs are available to treat
the proinammatory state. However, several drugs used to
treat other metabolic risk factors—statins, ﬁbrates, thia-
zolidinedione, and coenzyme Q10, have been reported to
reduce concentrations of C-reactive proteins and cytokines.
However, these agents (accept w-3 fatty acids, coenzyme
Q10 or a Mediterranean diet or a DASH diet), cannot
be recommended speciﬁcally to reduce a proinﬂammatory
state independent of other risk factors [125, 131]. The
association between overall dietary patterns and mortality
due to cardiovascular disease and other chronic diseases
is not unknown. In one study [132], a population of
>70000 apparently healthy US women over the course of
18 years, was followed, assessing dietary intake repeatedly.
By applying factor analysis, the authors identiﬁed 2 major
dietary patterns. A greater adherence to the pattern labeled
as prudent (characterized by a high consumption of plant
foods such as vegetables, fruit, legumes, and whole grains
as well as ﬁsh and poultry) was related to a 28% reduced
risk of cardiovascular disease mortality and a 17% reduced
risk of premature all-cause mortality. By contrast, a greater
adherence to the pattern labeled as western (characterized
by a high consumption of red and processed meat, reﬁned
grains, french fries, and sweets) was associated with a 22%
increased risk of cardiovascular disease mortality, a 16%
increased risk of cancer mortality, and a 21% increased risk
of premature all-cause mortality. The observed associations
were independent of known risk factors including age,
smoking, physical inactivity, body mass index, and total
caloric intake. Nutritional recommendations to prevent
chronic diseases and promote longevity may need to focus
on overall dietary patterns rather than individual nutrients.
This large cohort study further conﬁrms the ﬁndings of
Lyon heart study and the Indo-Mediterranean diet heart
study as well as other views regarding protective eﬀects
of Columbus foods in the prevention of CVD and all
cause mortality [27, 133]. NCX1.3 is more sensitive to
inhibition by ALA than NCX1.1. In addition, only w-3 PUFA
inhibits NCX1.1, but several classes of fatty acids inhibit
NCX1.3. The diﬀerential sensitivity of NCX isoforms to
fatty acids may have important implications as therapeutic
approaches for hypertension, heart failure, and arrhythmias
[134].
Acknowledgments
The authors appreciate Columbus Paradigm Institute, Bel-
gium,andTsimTsoumInstitute,Krakow,Polandforsupport
to write this paper. The authors are grateful to International
College of Nutrition and International College of Cardiology
for logistics and academic support.
References
[1] World Health Organization, Preventing Chronic Disease: A
Vital Investment World Heath Organization, World Health
Organization, Geneva, Switzerland, 2005.
[2] A. Indrayan, “Forecasting vascular disease cases and
associated mortality in India,” 2007, http://www.whoindia.
org/LinkFiles/Commision on Macreconomic and Health
Bg P2 Forecasting vascular disease cases and associated
mortality in India.pdf.
[3] S. B. Eaton, S. B. Eaton III, A. J. Sinclair, I. Cordain, and N.
J. Mann, “Dietary intake of long chain polyunsaturated fatty
acidsduringthePaleilithicperiod.InSimopoulosAPedition.
The return of w-3 fatty acids in the food supply. Land based
animal food products and their health eﬀects,” World Review
of Nutrition And Dietetics, vol. 83, pp. 12–23, 1998.14 Cardiology Research and Practice
[4] “American Heart Association Heart and Stroke Statisti-
cal Update,” 2008, www.americanheart.org/downloadable
/heart/1200078608862HS Stats%202008.ﬁnal.pdf.
[5] R.B.Singh,V.Singh,S.K.Kulshresthaetal.,“Socialclassand
all-cause mortality in an urban population of North India,”
Acta Cardiologica, vol. 60, no. 6, pp. 611–617, 2005.
[ 6 ]R .G u p t a ,A .M i s r a ,P .P a i s ,P .R a s t o g i ,a n dV .P .G u p t a ,
“Correlation of regional cardiovascular disease mortality in
India with lifestyle and nutritional factors,” International
Journal of Cardiology, vol. 108, no. 3, pp. 291–300, 2006.
[7] V. Gajalakshmi, R. Peto, S. Kanaka, and S. Balasubramanian,
“Verbal autopsy of 48 000 adult deaths attributable to
medical causes in Chennai (formerly Madras), India,” BMC
Public Health, vol. 2, no. 1, p. 7, 2002.
[8] R. Joshi, M. Cardona, S. Iyengar et al., “Chronic diseases now
a leading cause of death in rural India: mortality data from
the Andhra Pradesh rural health initiative,” International
Journal of Epidemiology, vol. 35, no. 6, pp. 1522–1529, 2006.
[9] V. Mohan, C. S. Shanthirani, M. Deepa, R. Deepa, R. I.
Unnikrishnan,andM.Datta,“Mortalityratesduetodiabetes
in a selected Urban south Indian population—the Chennai
urban population study [CUPS-16],” Journal of Association
of Physicians of India, vol. 54, pp. 113–117, 2006.
[10] A. Goyal and S. Yusuf, “The burden of cardiovascular
diseaseintheIndiansubcontinent,”IndianJournalofMedical
Research, vol. 124, no. 3, pp. 235–244, 2006.
[11] N. Chaturvedi and J. H. Fuller, “Ethnic diﬀerences in
mortality from cardiovascular disease in the UK: do they
persist in people with diabetes?” Journal of Epidemiology and
Community Health, vol. 50, no. 2, pp. 137–139, 1996.
[12] N. Chaturvedi, J. Jarrett, N. Morrish, H. Keen, and J. H.
Fuller, “Diﬀerences in mortality and morbidity in African
CaribbeanandEuropeanpeoplewithnon-insulindependent
diabetes mellitus: results of 20 year follow up of a London
cohort of a multinational study,” British Medical Journal, vol.
313, no. 7061, pp. 848–852, 1996.
[13] N. G. Forouhi, N. Sattar, T. Tillin, P. M. McKeigue, and
N. Chaturvedi, “Do known risk factors explain the higher
coronary heart disease mortality in South Asian compared
with European men? Prospective follow-up of the Southall
and Brent studies, UK,” Diabetologia, vol. 49, no. 11, pp.
2580–2588, 2006.
[14] A. P. Simopoulos, “Importance of the ratio of omega-
6/omega-3 essential fatty acids: evolutionary aspects,” World
review of nutrition and dietetics, vol. 92, pp. 1–22, 2003.
[15] F. De Meester, “Wild-type land based foods in health
promotion and disease prevention: the LDL-CC:HDL-CC
model,” in Wild Type Foods in Health Promotion and Disease
Prevention,F .D eM e e s t e ra n dR .R .W a t s o n ,E d s . ,p p .3 – 2 0 ,
Humana Press, Totowa, NJ, USA, 2008.
[16] T. T. Fung, S. E. Chiuve, M. L. McCullough, K. M. Rexrode,
G. Logroscino, and F. B. Hu, “Adherence to a DASH-style
diet and risk of coronary heart disease and stroke in women,”
Archives of Internal Medicine, vol. 168, no. 7, pp. 713–720,
2008.
[17] F. M. Sacks, L. P. Svetkey, W. M. Vollmer et al., “Eﬀects on
blood pressure of reduced dietary sodium and the Dietary
Approaches to Stop Hypertension (DASH) diet,” The New
England Journal of Medicine, vol. 344, no. 1, pp. 3–10, 2001.
[18] E. Obarzanek, F. M. Sacks, W. M. Vollmer et al., “Eﬀects on
blood lipids of a blood pressure-lowering diet: the Dietary
Approaches to Stop Hypertension (DASH) trial,” American
Journal of Clinical Nutrition, vol. 74, no. 1, pp. 80–89, 2001.
[19] H. I. Katcher, R. S. Legro, A. R. Kunselman et al., “The eﬀects
of a whole grain-enriched hypocaloric diet on cardiovascular
disease risk factors in men and women with metabolic
syndrome,” American Journal of Clinical Nutrition, vol. 87,
no. 1, pp. 79–90, 2008.
[20] C. Zhang, K. M. Rexrode, R. M. van Dam, T. Y. Li, and
F. B. Hu, “Abdominal obesity and the risk of all-cause,
cardiovascular, and cancer mortality: sixteen years of follow-
up in US women,” Circulation, vol. 117, no. 13, pp. 1658–
1667, 2008.
[21] W. S. Harris, K. J. Reid, S. A. Sands, and J. A. Spertus, “Blood
omega-3 and trans fatty acids in middle aged acute coronary
syndrome patients,” American Journal of Cardiology, vol. 99,
no. 2, pp. 154–158, 2007.
[22] R. B. Singh, J. Fedacko, D. Pella, F. De Meester, M. Moshiri,
and W. E. Arousy, “ Super foods dietary approaches for acute
myocardial infarction,” World Heart Journal, vol. 2, pp. 1–8,
2009.
[23] C.R.HarperandT.A.Jacobson,“Usefulnessofomega-3fatty
acidsandthepreventionofcoronaryheartdisease,”American
Journal of Cardiology, vol. 96, no. 11, pp. 1521–1529, 2005.
[24] D. Mozaﬀa r i a n ,A .G e e l e n ,I .A .B r o u w e r ,J .M .G e l e i j n s e ,P .
L. Zock, and M. B. Katan, “Eﬀect of ﬁsh oil on heart rate
in humans: a meta-analysis of randomized controlled trials,”
Circulation, vol. 112, no. 13, pp. 1945–1952, 2005.
[25] D. M. Lloyd-Jones, K. Liu, L. A. Colangelo et al., “Con-
sistently stable or decreased body mass index in young
adulthood and longitudinal changes in metabolic syndrome
components: the coronary artery risk development in young
adults study,” Circulation, vol. 115, no. 8, pp. 1004–1011,
2007.
[26] W. Rosamond, K. Flegal, G. Friday et al., “Heart disease and
stroke statistics—2007 update: a report from the American
Heart Association Statistics Committee and Stroke Statistics
Subcommittee,” Circulation, vol. 115, no. 5, pp. e69–e171,
2007.
[27] R.B.Singh,D.Pella,F.DeMeester,K.Otsuka,andR.Chopra,
“Fatty acids in the causation and prevention of metabolic
syndrome,” in Wild Foods and Health and Disease,R .R .
Watson and F. De Meester, Eds., pp. 263–284, Humana Press,
New York, NY, USA, 2008.
[28] K. Esposito and D. Giugliano, “Diet and inﬂammation: a link
to metabolic and cardiovascular diseases,” European Heart
Journal, vol. 27, no. 1, pp. 15–20, 2006.
[29] R. A. Vogel, “Eating, vascular biology, and atherosclerosis: a
lot to chew on,” European Heart Journal,v o l .2 7 ,n o .1 ,p p .
13–14, 2006.
[30] R. B. Singh, D. Pella, K. Kartikey, et al., “Prevalence of
obesity,physicalinactivityandundernutrition,atripleburden
of diseases,during transition in a middle income country,”
Acta Cardiologica, vol. 62, pp. 119–127, 1997.
[31] L. E. Eberly, R. Prineas, J. D. Cohen et al., “Metabolic
syndrome: risk factor distribution and 18-year mortality in
the multiple risk factor intervention trial,” Diabetes Care, vol.
29, no. 1, pp. 123–130, 2006.
[32] Z. Jiang and J. S. Sim, “Consumption of n-3 polyunsaturated
fatty acid-enriched eggs and changes in plasma lipids of
human subjects,” Nutrition, vol. 9, no. 6, pp. 513–518, 1993.
[33] Z. Sumbalov´ a, J. Kucharsk´ a, S. Kaˇ sparov´ a et al., “Brain
energy metabolism in experimental chronic diabetes: eﬀect
of long-term administration of coenzyme Q10 and Omega-
3 polyunsaturated fatty acids,” Biologia, vol. 60, no. 17, pp.
105–108, 2005.Cardiology Research and Practice 15
[34] I. G. E. Zarraga and E. R. Schwarz, “Impact of dietary
patterns and interventions on cardiovascular health,” Circu-
lation, vol. 114, no. 9, pp. 961–973, 2006.
[35] J. X. Kang, J. Wang, L. Wu, and Z. B. Kang, “Fat-1 mice
convert n-6 to n-3 fatty acids,” Nature, pp. 427–504, 2004.
[36] J.S.Drukteinis,M.J.Roman,R.R.Fabsitzetal.,“Cardiacand
systemic hemodynamic characteristics of hypertension and
prehypertension in adolescents and young adults: the Strong
Heart Study,” Circulation, vol. 115, no. 2, pp. 221–227, 2007.
[37] F. C. M. Lacroix and F. De Meester, “The return to wild-type
fatsinthediet,”NutritionBulletin,vol.32,no.2,pp.168–172,
2007.
[38] R. B. Singh, I. L. Suh, V. P. Singh et al., “Hypertension
and stroke in Asia: prevalence, control and strategies in
developing countries for prevention,” Journal of Human
Hypertension, vol. 14, no. 10-11, pp. 749–763, 2000.
[39] R. B. Singh, H. Mori, J. Chen et al., “Recommendations for
the prevention of coronary artery disease in Asians: a sci-
entiﬁc statement of the International College of Nutrition,”
Journal of Cardiovascular Risk, vol. 3, no. 6, pp. 489–494,
1996.
[40] R. B. Singh, M. A. Niaz, S. Ghosh et al., “Association of trans
fatty acids (vegetable ghee) and clariﬁed butter (Indian ghee)
intakewithhigherriskofcoronaryarterydiseaseinruraland
urban populations with low fat consumption,” International
Journal of Cardiology, vol. 56, no. 3, pp. 289–298, 1996.
[41] R. B. Singh, A. R. Sircar, S. S. Rastogi, and R. Singh, “Dietary
modulators of blood pressure in hypertension,” European
JournalofClinicalNutrition,vol.44,no.4,pp.319–327,1990.
[42] D.Pella,R.B.Singh,K.Otsuka,C.-A.Chiang,andS.R.Joshi,
“Nutritional predictors and modulators of insulin resis-
tance,” Journal of Nutritional and Environmental Medicine,
vol. 14, no. 1, pp. 3–16, 2004.
[43] R. B. Singh, S. S. Rastogi, V. Rastogi et al., “Blood pressure
trends, plasma insulin levels and risk factors in rural and
urban elderly populations of north India,” Coronary Artery
Disease, vol. 8, no. 7, pp. 463–468, 1997.
[44] D. Pella, R. B. Singh, B. Tomlinson, and C. W. Kong, “Coro-
nary artery disease in developing and newly industrialized
countries: a scientiﬁc statement of the International College
of Cardiology,” in Frontiers of Cardiovascular Health,N .S .
Dhalla, A . Chocklingham, H. J. Berkowitz, and P. K. Singal,
Eds., pp. 473–483, Kluwer Academic Publishers, Boston,
Mass, USA, 2003.
[45] R. B. Singh, D. Pella, J. P. Sharma et al., “Increased
concentrations of lipoprotein(a), circadian rhythms and
metabolic reactions evoked by acute myocardial infarction,
associatedwithacutereactionsinrelationtolargebreakfasts,”
Biomedicine and Pharmacotherapy, vol. 58, no. 1, supple-
ment, pp. S116–S122, 2004.
[46] R. B. Singh, D. Pella, N. S. Neki, et al., “Mechanism of acute
myocardial infarction study,” Biomedicine & Pharmacother-
apy, vol. 58, supplement, pp. 111–115, 2004.
[47] R. B. Singh, R. Beegom, S. P. Verma, et al., “Association of
dietary factors and other coronary risk factors with social
class in women in ﬁve Indian cities,” Asia Paciﬁc Journal of
Clinical Nutrition, vol. 9, no. 4, pp. 298–302, 2000.
[48] P. Benatti, G. Peluso, R. Nicolai, and M. Calvani, “Polyun-
saturated fatty acids: biochemical, nutritional and epigenetic
properties,” Journal of the American College of Nutrition, vol.
23, no. 4, pp. 281–302, 2004.
[49] A. P. Simopoulos, “Is insulin resistance inﬂuenced by dietary
linoleic acid and trans fatty acids?” Free Radical Biology and
Medicine, vol. 17, no. 4, pp. 367–372, 1994.
[50] R. B. Singh, M. A. Niaz, R. Beegom, G. S. Wander, A. S.
Thakur, and H. S. Rissam, “Body fat percent by bioelectrical
impedance analysis and risk of coronary artery disease
among urban men with low rates of obesity: the Indian
paradox,” Journal of the American College of Nutrition, vol.
18, no. 3, pp. 268–273, 1999.
[ 5 1 ]L .H .S t o r l i e n ,A .B .J e n k i n s ,D .J .C h i s h o l m ,W .S .P a s c o e ,
S. Khouri, and E. W. Kraegen, “Inﬂuence of dietary fat
composition on development of insulin resistance in rats.
Relationship to muscle triglyceride and ω-3 fatty acids in
muscle phospholipid,” Diabetes, vol. 40, no. 2, pp. 280–289,
1991.
[ 5 2 ]F .B .H u ,R .M .v a nD a m ,a n dS .L i u ,“ D i e ta n dr i s ko f
Type II diabetes: the role of types of fat and carbohydrate,”
Diabetologia, vol. 44, no. 7, pp. 805–817, 2001.
[53] B. A. Swinburn, “Eﬀect of dietary lipid on insulin action.
Clinical studies,” Annals of the New York Academy of Sciences,
vol. 683, pp. 102–109, 1993.
[54] M. Uusitupa, U. Schwab, S. Makimattila et al., “Eﬀects of
two high-fat diets with diﬀerent fatty acid compositions on
glucose and lipid metabolism in healthy young women,”
American Journal of Clinical Nutrition,v o l .5 9 ,n o .6 ,p p .
1310–1316, 1994.
[55] B. Vessby, M. Uusitupa, K. Hermansen et al., “Substituting
dietary saturated for monounsaturated fat impairs insulin
sensitivity in healthy men and women: the KANWU study,”
Diabetologia, vol. 44, no. 3, pp. 312–319, 2001.
[56] R. B. Singh, S. S. Rastogi, M. A. Niaz, and S. Ghosh, “Eﬀects
of fatmodiﬁed and fruits vegetable enriched diets on blood
lipids in the Indian diet heart study,” American Journal of
Cardiology, vol. 69, pp. 869–874, 1992.
[57] R. B. Singh, S. S. Rastogi, R. Singh, S. Ghosh, and M. A.
Niaz, “Eﬀects of guava intake on serum total and high-
density lipoprotein cholesterol levels and on systemic blood
pressure,” American Journal of Cardiology, vol. 70, no. 15, pp.
1287–1291, 1992.
[58] E. J. Mayer-Davis, J. H. Monaco, H. M. Hoen et al., “Dietary
fat and insulin sensitivity in a triethnic population: the
role of obesity. The Insulin Resistance Atherosclerosis Study
(IRAS),”AmericanJournalofClinicalNutrition,vol.65,no.1,
pp. 79–87, 1997.
[59] J. Salmer´ on, F. B. Hu, J. E. Manson et al., “Dietary fat intake
and risk of type 2 diabetes in women,” American Journal of
Clinical Nutrition, vol. 73, no. 6, pp. 1019–1026, 2001.
[60] N. Hwalla, N. Torbay, N. Andari, N. Adra, S. T. Azar, and
Z. Habbal, “Restoration of normal insulinemia and insulin
sensitivity in hyperinsulinemic normoglycemic men by a
hypoenergetic high monounsaturated fat diet,” Journal of
Nutritional and Environmental Medicine, vol. 14, no. 1, pp.
29–38, 2004.
[61] A. R. Folsom, J. Ma, P. G. McGovern, and J. H. Eckfeldt,
“Relation between plasma phospholipid saturated fatty acids
and hyperinsulinemia,” Metabolism, vol. 45, no. 2, pp. 223–
228, 1996.
[62] J. C. Lovejoy, C. M. Champagne, S. R. Smith et al.,
“Relationship of dietary fat and serum cholesterol ester and
phospholipid fatty acids to markers of insulin resistance
in men and women with a range of glucose tolerance,”
Metabolism, vol. 50, no. 1, pp. 86–92, 2001.
[63] C. C. Low, E. B. Grossman, and B. Gumbiner, “Potentiation
of eﬀects of weight loss by monounsaturated fatty acids in
obeseNIDDMpatients,”Diabetes,vol.45,no.5,pp.569–575,
1996.16 Cardiology Research and Practice
[64] B. Gumbiner, C. C. Low, and P. D. Reaven, “Eﬀects of a
monounsaturated fatty acid-enriched hypocaloric diet on
cardiovascular risk factors in obese patients with type 2
diabetes,” Diabetes Care, vol. 21, no. 1, pp. 9–15, 1998.
[65] L. K. Heilbronn, M. Noakes, and P. M. Clifton, “Eﬀect of
energy restriction, weight loss, and diet composition on
plasma lipids and glucose in patients with type 2 diabetes,”
Diabetes Care, vol. 22, no. 6, pp. 889–895, 1999.
[66] V. Ruiz-Guti´ errez, N. Morgado, J. L. Prada, F. P´ erez-Jim´ enez,
and F. J. G. Muriana, “Composition of human VLDL
triacylglycerols after ingestion of olive oil and high oleic
sunﬂower oil,” Journal of Nutrition, vol. 128, no. 3, pp. 570–
576, 1998.
[67] D. Pella, G. Dubnov, R. B. Singh, R. Sharma, E. M. Berry,
and O. Manor, “Eﬀects of an Indo-Mediterranean diet on the
omega-6/omega-3 ratio in patients at high risk of coronary
artery disease: the Indian paradox,” in World Review of
Nutrition and Dietetics, A. P. Simopoulos, L. G. Cleland, and
R. B. Karger, Eds., vol. 92, pp. 74–80, 2003.
[68] D. J. McNamara, “Dietary fatty acids, lipoproteins, and
cardiovascular disease,” Advances in Food and Nutrition
Research, vol. 36, pp. 253–351, 1992.
[69] M. B. Montalto and A. Bensadoun, “Lipoprotein lipase
synthesis and secretion: eﬀects of concentration and type of
fattyacidsinadipocytecellculture,”JournalofLipidResearch,
vol. 34, no. 3, pp. 397–407, 1993.
[70] A. Kafatos and G. E. Comas, “Biological eﬀect of olive oil
in human health,” in Olive Oil, A. Kiritsakis, Ed., p. 175,
American Oil Chemists Society, Champaign, Ill, USA, 1990.
[71] H. M. Roche, A. Zampelas, J. M. E. Knapper et al., “Eﬀect
of long-term olive oil dietary intervention on postprandial
triacylglycerol and factor VII metabolism,” American Journal
of Clinical Nutrition, vol. 68, no. 3, pp. 552–560, 1998.
[72] B. Blades and A. Garg, “Mechanisms of increase in plasma
triacylglycerolconcentrationsasaresultofhighcarbohydrate
intakes in patients with non-insulin-dependent diabetes
mellitus,” American Journal of Clinical Nutrition, vol. 62, no.
5, pp. 996–1002, 1995.
[73] B. Kiens, B. Essen-Gustavsson, P. Gad, and H. Lithell,
“Lipoprotein lipase activity and intramuscular triglyceride
stores after long-term high-fat and high-carbohydrate diets
in physically trained men,” Clinical Physiology, vol. 7, no. 1,
pp. 1–9, 1987.
[74] T. Hung, J. L. Sievenpiper, A. Marchie, C. W. C. Kendall,
and D. J. A. Jenkins, “Fat versus carbohydrate in insulin
resistance, obesity, diabetes and cardiovascular disease,”
CurrentOpinioninClinicalNutritionandMetabolicCare,vol.
6, no. 2, pp. 165–176, 2003.
[75] M. B. Schulze and F. B. Hu, “Dietary approaches to
prevent the metabolic syndrome: quality versus quantity of
carbohydrates,” Diabetes Care, vol. 27, no. 2, pp. 613–614,
2004.
[76] N. M. McKeown, J. B. Meigs, S. Liu, E. Saltzman, P. W. F.
Wilson, and P. F. Jacques, “Carbohydrate nutrition,insulin
resistance,and the prevalence of the metabolic syndrome in
the Framingham Oﬀspring cohort,” Diabetes Care, vol. 27,
no. 2, pp. 538–546, 2004.
[77] L. A. Bazzano, M. Serdula, and S. Liu, “Prevention of type
2 diabetes by diet and lifestyle modiﬁcation,” Journal of the
American College of Nutrition, vol. 24, no. 5, pp. 310–319,
2005.
[78] D. Pella, N. Thomas, B. Tomlinson, and R. B. Singh,
“Prevention of coronary artery disease: the south Asian
paradox,” The Lancet, vol. 361, no. 9351, p. 79, 2003.
[79] WHO, “Global strategy on Diet,Physical Activity and
Health,” The World Health Report, WHO, Geneva, Swizer-
land, 2004.
[80] C. A. M. Anderson and L. J. Appel, “Dietary modiﬁcation
andCVDprevention:amatteroffat,” J o urnalo ftheA merican
Medical Association, vol. 295, no. 6, pp. 693–695, 2006.
[81] T. G. Pickering, “New guidelines on diet and blood pressure,”
Hypertension, vol. 47, no. 2, pp. 135–136, 2006.
[82] M. A. Pereira, A. I. Kartashov, C. B. Ebbeling et al., “Fast-
food habits, weight gain, and insulin resistance (the CARDIA
study):15-yearprospectiveanalysis,”TheLancet,vol.365,no.
9453, pp. 36–42, 2005.
[83] S. E. Nissen, E. M. Tuzcu, P. Schoenhagen et al., “Reversal
Investigators.Eﬀect of intensive compared with moderate
lipidloweringtherapyonprogressionofcoronaryatheroscle-
rosis. A randomized controlled trial,” Journal of the American
Medical Association, vol. 291, no. 9, pp. 1071–1080, 2004.
[84] C. P. Cannon, E. Braunwald, C. H. McCabe, et al., “Pravas-
tatin or atorvastatin evaluation and infection therapy-
Thrombolysis in myocardial infarction 22 investigators.
Intensive verses moderate lipid lowering with statins after
acute coronary syndromes,” The New England Journal of
Medicine, vol. 350, pp. 1495–1504, 2004.
[85] K. Esposito, D. Giugliano, F. Nappo, and R. Marfella,
“Regressionofcarotidatherosclerosisbycontrolofpostpran-
dial hyperglycemia in type 2 diabetes mellitus,” Circulation,
vol. 110, no. 2, pp. 214–219, 2004.
[86] A. Ceriello, R. Assaloni, R. Da Ros et al., “Eﬀect of
atorvastatin and irbesartan, alone and in combination, on
postprandial endothelial dysfunction, oxidative stress, and
inﬂammation in type 2 diabetic patients,” Circulation, vol.
111, no. 19, pp. 2518–2524, 2005.
[87] R. H. B¨ oger, “Association of asymmetric dimethylarginine
and endothelial dysfunction,” Clinical Chemistry and Labo-
ratory Medicine, vol. 41, no. 11, pp. 1467–1472, 2003.
[ 8 8 ] K .E s p o s i t o ,F .N a p p o ,F .G i u g l i a n o ,G .G i u g l i a n o ,R .
Marfella, and D. Giugliano, “Eﬀect of dietary antioxidants
on postprandial endothelial dysfunction induced by a high-
fat meal in healthy subjects,” American Journal of Clinical
Nutrition, vol. 77, no. 1, pp. 139–143, 2003.
[89] P. E. Bowen and G. Borthakur, “Postprandial lipid oxida-
tion and cardiovascular disease risk,” Current Atherosclerosis
Reports, vol. 6, no. 6, pp. 477–484, 2004.
[90] A. Ceriello and E. Motz, “Is oxidative stress the pathogenetic
mechanism underlying insulin resistance, diabetes and car-
diovascular disease? The common soil hypothesis revisited,”
Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no.
5, pp. 816–823, 2004.
[91] P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R.
Garg, “Metabolic syndrome: a comprehensive perspective
based on interactions between obesity, diabetes, and inﬂam-
mation,” Circulation, vol. 111, no. 11, pp. 1448–1454, 2005.
[92] K. Esposito, F. Nappo, R. Marfella et al., “Inﬂammatory
cytokine concentrations are acutely increased by hyper-
glycemia in humans: role of oxidative stress,”Circulation, vol.
106, no. 16, pp. 2067–2072, 2002.
[93] A. Ceriello, L. Quagliaro, B. Catone, et al., “Role of hyper-
glycemia in nitrotyrosine postprandial generation,” Diabetes
Care, vol. 25, no. 8, pp. 1439–1443, 2002.
[94] K. Esposito, F. Nappo, F. Giugliano et al., “Meal modulation
of circulating interleukin 18 and adiponectin concentrations
in healthy subjects and in patients with type 2 diabetes
mellitus,” American Journal of Clinical Nutrition, vol. 78, no.
6, pp. 1135–1140, 2003.Cardiology Research and Practice 17
[95] P. A. Tataranni and E. Ortega, “A burning question: does an
adipokine-induced activation of the immune system mediate
the eﬀect of overnutrition on type 2 diabetes?” Diabetes, vol.
54, no. 4, pp. 917–927, 2005.
[96] J. S. Pankow, B. B. Duncan, M. I. Schmidt et al., “Fasting
plasma free fatty acids and risk of type 2 diabetes: the
Atherosclerosis risk in communities study,” Diabetes Care,
vol. 27, no. 1, pp. 77–82, 2004.
[97] J. B. Meigs, F. B. Hu, N. Rifai, and J. E. Manson, “Biomarkers
of endothelial dysfunction and risk of type 2 diabetes
mellitus,” Journal of the American Medical Association, vol.
291, no. 16, pp. 1978–1986, 2004.
[98] F. Kim, K. A. Tysseling, J. Rice et al., “Free fatty acid
impairment of nitric oxide production in endothelial cells is
mediatedbyIKKβ,” Arteriosclerosis,Thrombosis,andVascular
Biology, vol. 25, no. 5, pp. 989–994, 2005.
[99] Z. Gao, D. Hwang, F. Bataille et al., “Serine phosphorylation
of insulin receptor substrate 1 by inhibitor κB kinase
complex,” The Journal of Biological Chemistry, vol. 277, no.
50, pp. 48115–48121, 2002.
[100] D. Cai, M. Yuan, D. F. Frantz et al., “Local and systemic
insulin resistance resulting from hepatic activation of IKK-
β and NF-κB,” Nature Medicine, vol. 11, no. 2, pp. 183–190,
2005.
[101] T. Yamauchi, J. Kamon, H. Waki et al., “The fat-derived
hormone adiponectin reverses insulin resistance associated
with both lipoatrophy and obesity,” Nature Medicine, vol. 7,
no. 8, pp. 941–946, 2001.
[102] E. Lopez-Garcia, M. B. Schulze, J. B. Meigs et al., “Con-
sumption of trans fatty acids is related to plasma biomarkers
of inﬂammation and endothelial dysfunction,” Journal of
Nutrition, vol. 135, no. 3, pp. 562–566, 2005.
[103] M. Pirro, G. Schillaci, G. Savarese et al., “Attenuation of
inﬂammation with short-term dietary intervention is asso-
ciated with a reduction of arterial stiﬀness in subjects with
hypercholesterolaemia,” European Journal of Cardiovascular
Prevention and Rehabilitation, vol. 11, no. 6, pp. 497–502,
2004.
[104] E. Lopez-Garcia, M. B. Schulze, J. E. Manson et al.,
“Consumption of (n-3) fatty acids is related to plasma
biomarkers of inﬂammation and endothelial activation in
women,” Journal of Nutrition, vol. 134, no. 7, pp. 1806–1811,
2004.
[105] P.M. Kris-Etherton, A. H. Lichtenstein, B. V. Howard, D.
Steinberg, and J. L. Witztum, “Antioxidant vitamin supple-
ments and cardiovascular disease,” Circulation, vol. 110, no.
5, pp. 637–641, 2004.
[106] D. C. W. Lau, B. Dhillon, H. Yan, P. E. Szmitko, and S.
Verma, “Adipokines: molecular links between obesity and
atheroslcerosis,” American Journal of Physiology, vol. 288, no.
5, pp. H2031–H2041, 2005.
[107] M. A. Pereira, A. I. Kartashov, C. B. Ebbeling et al., “Fast-
food habits, weight gain, and insulin resistance (the CARDIA
study):15-yearprospectiveanalysis,”TheLancet,vol.365,no.
9453, pp. 36–42, 2005.
[108] V. Drapeau, J.-P. Despr´ es, C. Bouchard et al., “Modiﬁcations
in food-group consumption are related to long-term body-
weight changes,” American Journal of Clinical Nutrition, vol.
80, no. 1, pp. 29–37, 2004.
[109] R. B. Singh, G. Dubnov, M. A. Niaz et al., “Eﬀe c to fa nI n d o -
Mediterranean diet onprogressionof coronaryartery disease
inhighriskpatients(Indo-MediterraneanDietHeartStudy):
a randomised single-blind trial,” The Lancet, vol. 360, no.
9344, pp. 1455–1461, 2002.
[110] K. Esposito, R. Marfella, M. Ciotola et al., “Eﬀect of a
Mediterranean-style diet on endothelial dysfunction and
markers of vascular inﬂammation in the metabolic syn-
drome: a randomized trial,” Journal of the American Medical
Association, vol. 292, no. 12, pp. 1440–1446, 2004.
[111] H. Iso, M. Kobayashi, J. Ishihara, et al., “Intake of ﬁsh and n3
fattyacidsandriskofcoronaryheartdiseaseamongJapanese:
the Japan Public Health Center-Based (JPHC) study cohort
I,” Circulation, vol. 113, no. 2, pp. 195–202, 2006.
[112] A.Gramenzi,A.Gentile,M.Fasoli,E.Negri,F.Parazzini,and
C. La Vecchia, “Association between certain foods and risk
of acute myocardial infarction in women,” British Medical
Journal, vol. 300, no. 6727, pp. 771–773, 1990.
[113] R. B. Singh, M. A. Niaz, P. Agarwal, R. Begom, and S. S.
Rastogi, “Eﬀect of antioxidant-rich foods on plasma ascorbic
acid, cardiac enzyme, and lipid peroxide levels in patients
hospitalized with acute myocardial infarction,” Journal of the
American Dietetic Association, vol. 95, no. 7, pp. 775–780,
1995.
[114] K. T. B. Knoops, L. C. P. G. M. de Groot, D. Kromhout et al.,
“Mediterranean diet, lifestyle factors, and 10-year mortality
in elderly European men and women: the HALE project,”
Journal of the American Medical Association, vol. 292, no. 12,
pp. 1433–1439, 2004.
[115] A. Trichopoulou, T. Costacou, C. Bamia, and D. Trichopou-
los, “Adherence to a Mediterranean diet and survival in a
Greekpopulation,”TheNewEnglandJournalofMedicine,vol.
348, no. 26, pp. 2599–2608, 2003.
[116] M. De Lorgeril, P. Salen, J.-L. Martin, I. Monjaud, J.
Delaye, and N. Mamelle, “Mediterranean diet, traditional
riskfactors,andtherateofcardiovascularcomplicationsafter
myocardial infarction: ﬁnal report of the Lyon Diet Heart
Study,” Circulation, vol. 99, no. 6, pp. 779–785, 1999.
[117] R. B. Singh, S. S. Rastogi, R. Verma, L. Bolaki, and R. Singh,
“An Indian experiment with nutritional modulation in acute
myocardial infarction,” American Journal of Cardiology, vol.
69, no. 9, pp. 879–885, 1992.
[118] R. B. Singh, M. A. Niaz, and C. Kartik, “Can n-3 fatty
acidsprovidemyocardialprotectionbydecreasinginfarctsize
and inhibiting atherothrombosis?” European Heart Journal,
Supplement, vol. 3, no. 4, pp. D62–D69, 2001.
[119] R. B. Singh, M. A. Niaz, J. P. Sharma, R. Kumar, V. Ras-
togi, and M. Moshiri, “Randomized, double-blind, placebo-
controlled trial of ﬁsh oil and mustard oil in patients with
suspectedacutemyocardialinfarction:theIndianexperiment
of infarct survival-4,” Cardiovascular Drugs and Therapy, vol.
11, no. 3, pp. 485–491, 1997.
[120] R. Marchioli, “Dietary supplementation with n-3 polyunsat-
urated fatty acids and vitamin E after myocardial infarction:
results of the GISSI-Prevenzione trial,” Lancet, vol. 354, no.
9177, pp. 447–455, 1999.
[121] R. Robinson, “The fetal origins of adult disease: no longer
just a hypothesis and may be critically important in south
Asia,”BritishMedicalJournal,vol.322,no.7283,pp.375–376,
2001.
[122] G. S. Kumar, U. N. Das, K. V. Kumar, N. Madhavi, N. P. Das,
a n dB .K .H .T a n ,“ E ﬀect of n-6 and n-3 fatty acids on the
proliferation of human lymphocytes and their secretion of
TNF-α a n dI L - 2i nv i t r o , ”Nutrition Research, vol. 12, no. 7,
pp. 815–823, 1992.
[123] S. Endres, R. Ghorbani, V. E. Kelley et al., “The eﬀect
of dietary supplementation with n-3 polyunsaturated fatty
acids on the synthesis of interleukin-1 and tumor necrosis18 Cardiology Research and Practice
factor by mononuclear cells,” The New England Journal of
Medicine, vol. 320, no. 5, pp. 265–271, 1989.
[124] L. V. Borovikova, S. Ivanova, M. Zhang et al., “Vagus nerve
stimulation attenuates the systemic inﬂammatory response
to endotoxin,” Nature, vol. 405, no. 6785, pp. 458–462, 2000.
[125] M. L. Burr, A. M. Fehily, J. F. Gilbert et al., “Eﬀects of
changesinfat,ﬁsh,andﬁbreintakesondeathandmyocardial
reinfarction: diet and reinfarction trial (DART),” The Lancet,
vol. 2, no. 8666, pp. 757–761, 1989.
[126] H. Wang, M. Yu, M. Ochani, et al., “Nicotinic acetylecholine
receptor alpha-7 subunit is an essential regulator of inﬂam-
mation,” Nature , vol. 421, pp. 384–388, 2003.
[127] R. B. Singh, M. A. Niaz, and C. Kartik, “Can n-3 fatty
acidsprovidemyocardialprotectionbydecreasinginfarctsize
and inhibiting atherothrombosis?” European Heart Journal,
Supplement, vol. 3, supplement 4, pp. D62–D69, 2001.
[128] C.R.HarperandT.A.Jacobson,“Usefulnessofomega-3fatty
acidsandthepreventionofcoronaryheartdisease,”American
Journal of Cardiology, vol. 96, no. 11, pp. 1521–1529, 2005.
[129] D. Mozaﬀarian, A. Geelen, I. A. Brouwer, J. M. Geleijnse, P.
L. Zock, and M. B. Katan, “Eﬀect of ﬁsh oil on heart rate
in humans: a meta-analysis of randomized controlled trials,”
Circulation, vol. 112, no. 13, pp. 1945–1952, 2005.
[130] J. A. Whitworth, “World Health Organization (WHO)/
International Society of Hypertension (ISH) statement on
management of hypertension,” Journal of Hypertension, vol.
21, no. 11, pp. 1983–1992, 2003.
[131] J.S.Drukteinis,M.J.Roman,R.R.Fabsitzetal.,“Cardiacand
systemic hemodynamic characteristics of hypertension and
prehypertension in adolescents and young adults: the Strong
Heart Study,” Circulation, vol. 115, no. 2, pp. 221–227, 2007.
[132] C. Heidemann, M. B. Schulze, O. H. Franco, R. M. Van Dam,
C. S. Mantzoros, and F. B. Hu, “Dietary patterns and risk of
mortality from cardiovascular disease, cancer, and all causes
in a prospective cohort of women,” Circulation, vol. 118, no.
3, pp. 230–237, 2008.
[133] F. De Meester, “Progress in lipid nutrition: the Columbus
concept addressing chronic diseases,” in World Review of
Nutrition and Dietetics, A. P. Simopoulos and F. De Meester,
Eds., vol. 100 of A Balanced Omega-6/Omega-3 Fatty Acid
Ratio, Cholesterol and Coronary Heart Disease series, pp. 110–
121, Karger, Basel, Germany, 2009.
[134] B. P. Ander, C. Hurtado, C. S. Raposo et al., “Diﬀerential
sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na
+-
Ca
2+exchanger to α-linolenic acid,” Cardiovascular Research,
vol. 73, no. 2, pp. 395–403, 2007.